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ABSTRACT 
 
Lower extremity peripheral arterial disease (PAD), which results from peripheral 
atherosclerosis, affects up to 10 million people in the United States alone.  This number is 
expected to increase in proportion to the increase in number of elderly in the population.  
Claudication, defined as a walking-induced pain in one or both legs relieved by rest, is 
the primary symptom of lower extremity PAD, and causes significant disability in many 
patients.  As the disease progresses, functional capacity is lost as claudication is induced 
with even minimal activity, and can progress to rest pain and gangrene.  The three main 
treatment options for PAD are lifestyle management, medical therapy, and surgical 
intervention.  Lifestyle management has been found to be highly effective; specifically, 
exercise adoption and smoking cessation have become the cornerstones of managing 
claudication pain.  Vascular nurses play a critical role in the collaborative care of PAD 
patients by offering counseling to change unhealthy behaviors, yet patients experience 
problems in actually overcoming sedentary lifestyle and nicotine addiction remains.  
Because the utility of exercise adoption and smoking cessation in treating claudication 
has been well documented, the purpose of the current study was to identify factors that 
promote the adoption and maintenance of exercise and smoking cessation behaviors with 
PAD patients.  Therefore, a pretest-posttest control group design with a 12-week exercise  
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and smoking cessation intervention was implemented, with outcome measures assessed at 
baseline, 3 and 6 months post enrollment. 
The foundational model used for developing this intervention study was the 
Transtheoretical Model of Behavior Change (TTM).  The core constructs from the TTM 
that were measured were stages of change, decisional balance, and self-efficacy.  While 
the TTM provided the structure for this intervention, principles of nicotine addiction and 
exercise determinants were used to develop personalized, stage-specific interventions.  In 
addition, functional status, defined as pain free walking time (claudication pain time 
[CPT]) and maximal walking time (MWT) in minutes and seconds, was measured.   
Data was available for analysis with 30 participants, 14 in the intervention group, 
and 16 in the usual care group.  The intervention group did have significant increases (p < 
.05) from baseline in CPT at 3 and 6 months, and in MWT at 3-months only.  There were 
no significant improvements in either functional status measure over time for the usual 
care group.  There were no changes in exercise decisional balance scores over time for 
either group.  Exercise self-efficacy did not change over time for the intervention group, 
but did significantly decrease (p < .05) at 6 months from baseline for the usual care 
group.  In addition, there was a significant difference between groups (p < .05) for 
exercise stage of change at 3-months, but not at 6 months.  There were no significant 
changes in either smoking decisional balance or smoking stage of change over time by 
group.  As a result, all smokers data (n = 15) were collapsed and analyzed, with 
differences and trends discussed, and themes identified. 
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Results from this study support the premise that a nurse-managed, theory based 
exercise adoption intervention is effective in helping claudicants adopt a routine exercise 
program.  In addition, when combined with a critical health event, a nurse-implemented, 
theory-based smoking cessation intervention may contribute to claudicants successful 
smoking cessation. 
As the incidence of PAD in the elderly population continues to increase, there will 
be a great demand for nurses to intervene to help claudicants make lifestyle changes that 
are know to be beneficial.  Vascular nurses must lead the way in investigating the most 
effective means for counseling patients to begin regular exercise and quit smoking.   
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CHAPTER 1 
 
INTRODUCTION 
 Lower extremity peripheral arterial disease (PAD) is a result of peripheral 
atherosclerosis, usually in the aortic, iliac, femoral, or popliteal arteries.  PAD affects 
approximately 8-10 million people in the United States alone, and this number is 
expected to increase in proportion to the increase in number of elderly in the population 
(Rockson and Cooke, 1998).   Claudication, which is defined as walking-induced pain in 
one or both legs relieved by rest, is the primary symptom of lower extremity PAD 
(Fahey, 1999).  Vascular nurses play a critical role in the collaborative care of PAD 
patients by offering lifestyle modification counseling, teaching patients about pertinent 
medications, and caring for patients after various invasive vascular procedures. 
Peripheral arterial disease causes significant disability in many patients due to 
decreased functional capacity related to activity associated limb pain, also known as 
claudication.  If untreated, PAD can progress to severe rest pain in the calf and feet, 
gangrene in the toes and feet, and finally amputation, which occurs in 3-8% of these 
patients every year (Hirsch, Treat-Jacobson, Lando, and Hatsukami, 1997).  Risk factors 
for PAD include smoking, elevated blood lipids (cholesterol and triglycerides), 
hypertension, and diabetes (Hirsch, et al., 1997; Stewart, Hiatt, Regensteiner, and Hirsch,  
2
 
2002).  In addition, although sedentary lifestyle does not cause PAD, it can contribute to 
symptomatic progression of the disease from muscle deconditioning that may lead to a 
house-bound status (Stewart et al., 2002).   Furthermore, there is a strong relationship 
between increasing mortality and decreasing systolic ankle pressures from peripheral 
atherosclerosis (p < .0001) (McKenna, Wolfson, and Kuller, 1991).  The 5-year mortality 
rate of patients with intermittent claudication is two to three times that of the general 
population (Gajraj and Jamieson, 1994).  This high mortality rate is generally a result of a 
myocardial infarction, and in fact the reported prevalence of coronary artery disease in 
patients with PAD has been reported as high as 92% (Gajraj and Jamieson, 1994).   
While symptomatology, including claudication pain, is crucial in the diagnosis of 
lower extremity PAD, the ankle-to-arm ratio of systolic blood pressure (ankle-brachial 
index [ABI]), is also a critical indicator of lower extremity atherosclerosis.  An ABI is 
readily obtainable with a standard blood-pressure cuff and a Doppler device (Stewart, 
2002; Hiatt, 2001).  This procedure involves having the patient lay supine, while an arm 
(brachial) systolic pressure is measured with the cuff and Doppler, followed by 
measurement of the ankle (dorsalis pedis and posterior tibial) pressures using the same 
equipment.  In a normal healthy person with no PAD, the ankle pressure is equal to or 
slightly higher than the arm pressure due to the highly resistant vascular bed in the lower 
extremity (Fahey, 1999).  Hence, when the arm pressure is divided into the ankle 
pressure, a ratio of 1.0 or greater is obtained.  However, when PAD is present, the ankle 
pressure is less than the arm pressure, and the ratio is less than 1.0.  In fact, the ABI is 
used as an index of the severity of peripheral arterial disease.  Normal flow yields an ABI 
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of >.95, mildly abnormal shows an ABI of .80-.95, claudication will result from an ABI 
of .40-.75, and an ABI of <.40 results in resting pain, ischemia, and the risk of gangrene 
(Fahey, 1999).   In addition to measuring ABI, the severity of claudication symptoms are 
also determined by having a patient walk on a treadmill.   During a standardized walking 
test with a consistent speed and grade, claudication pain time (CPT) is recorded, which is 
the amount of time the patient can walk before they begin to have pain in the affected 
extremity.  In addition, maximal walking time (MWT) is recorded, which is the maximal 
amount of time a claudicant can walk until maximal extremity pain forces them to stop.  
There are several therapies available for treating claudication.  These include 
lifestyle changes (e.g. smoking cessation and exercise training), medical management 
(e.g. lipid lowering medications, antiplatelets, and medications to enhance blood flow), 
and surgical management (e.g. peripheral angioplasty or bypass surgery) (Hirsch et al., 
1997; Stewart et al., 2002).  Medical and surgical management are generally reserved for 
patients with more severe claudication.  In contrast, lifestyle changes have been found to 
be highly effective as a first-line treatment for claudication.  Regular exercise training has 
been found to significantly increase time to initial CPT, and increase total MWT 
(Gardner and Poehlman, 1995).  In addition, smoking cessation has been found to prevent 
progression of stable claudication symptoms to more severe ischemia requiring surgery 
or amputation (Fahey, 1999).   
While exercise training and smoking cessation are two highly effective treatments 
for intermittent claudication, helping claudicants make these lifestyle changes can be very 
challenging for vascular nurses (Christman, Ahijevych, and Buckworth, 2001).  As a 
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result, a research study was developed and implemented in order to determine the 
effectiveness of a nurse-managed, theory based exercise adoption and smoking cessation 
intervention with claudicants.  Because we already knew that exercise training and 
smoking cessation were effective treatments for PAD, we were particularly interested in 
the factors that promote the adoption and maintenance of exercise and smoking cessation 
behaviors with PAD patients.  This study was developed in collaboration with several 
vascular surgeons in the greater Columbus area, and subjects were referred and recruited 
from five different vascular surgery offices in the city.   
A literature review about exercise training with PAD patients completed prior to 
the study revealed that the predictors of change in claudication pain distances during 
exercise were independently related to three exercise program components: 1) 
incorporating near maximal claudication pain end point (near maximum walk time) 
during the exercise training program, 2) at least 26 weeks of exercise, 3 times/week for at 
least 30 minutes/session, and 3) walking as the mode of exercise (Gardner and Poehlman, 
1995).  Furthermore, theory based smoking cessation interventions were found to be 
more effective than non-theory based interventions (Prochaska, DiClemente, Velicer, and 
Rossi, 1993).  As a result, the three important exercise components were integrated into 
the program, and three theoretical models were used to develop the intervention: the 
Trantheoretical Model, the Model of Nicotine Addiction, and Exercise Determinants.   
While the current study utilized a strong theoretical base to determine the 
effectiveness of a home based exercise adoption and smoking cessation program 
compared to usual care (control), there was a study conducted in 1997 by Patterson and 
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colleagues that was used to guide development of the current intervention.   In 1997, a 
published study reported the differences between supervised and home based exercise for 
patients with intermittent claudication (Patterson, Pinto, Marcus, Colucci, Braun, and 
Roberts, 1997).  The intervention for both groups included a 12-week class with a 
comprehensive curriculum covering such things as how to control hypertension, 
cholesterol, and diabetes, along with exercise training principles.  Because PAD 
management includes more than just exercise and smoking cessation, it was determined 
that a similar class would be the basis for the current 12-week intervention class.  The 
following chapters reveal that the nurses involved in the 1997 study were contacted and 
provided information about their program, which was used as a curricular guide for the 
current study.  In the current study, the specific week-by-week curriculum for the 
intervention group class included the following: etiology of PAD, principles of exercise 
training, principles of smoking cessation, hypertension, coronary artery disease, healthy 
eating, cholesterol management, diabetes, foot care, stress management, current 
medications (what subjects were currently taking), and maintaining the change.   
The following chapters are broken down according to the guidelines of the Ohio 
State University College of Nursing, which require three publishable papers be produced 
from doctoral research.  Chapter two is an article that has already been published in the 
Journal of Cardiovascular Nursing, and addresses the problem of PAD, along with a 
detailed analysis of the important components of an exercise training and smoking 
cessation program specific to claudicants (Christman et al., 2001).  Chapter three is a 
manuscript that will be submitted to the Journal of Vascular Nursing, and describes in 
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detail the theoretical base of the current study.   Chapter four will be submitted to the 
Journal of Vascular Surgery, and reports the methods and results of the current study, 
along with a discussion of the results.  Finally, chapter five provides a brief summary of 
the dissertation, along with recommendations for future research. 
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CHAPTER 2 
 
EXERCISE TRAINING AND SMOKING CESSATION AS THE CORNERSTONES 
OF MANAGING CLAUDICATION 
The chief complaint of those who suffer from lower extremity peripheral arterial 
disease (PAD) is intermittent claudication.  Claudication, derived from the Latin 
infinitive to limp (claudicare), is defined as cramping muscle pain that occurs 
predictably each time a given distance is walked, and is relieved after a period of rest 
(Fahey, 1999).  Claudication is a result of arterial occlusion (usually due to an 
atherosclerotic plaque) in the aortic, iliac, femoral, or popliteal arteries.  Claudication 
pain is always experienced distal to the site of occlusion, and may be located in the 
gluteal muscle, hip, thigh, or calf (Fowkes, 1997).   
PAD affects approximately 30% of older individuals in the general population 
(Gardner and Poehlman, 1995).   With the estimated increase in the elderly population to 
67 million by the year 2040, over one million elderly persons could develop symptomatic 
PAD every two years for the next 50 years (Rockson and Cooke, 1998).   Based on 
research, the classic recommendation to prevent progression of lower extremity PAD 
given by clinicians is start exercising and quit smoking (Lindgarde, Jelnes, Bjorkman, 
et al., 1989).  Unfortunately, a paramount problem for nurses is motivating targeted 
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individuals with PAD to begin and adhere to an exercise regimen, and/or quit smoking.  
While advances in the pharmacological management of PAD have been made recently, 
for many patients, it is minimally effective in reducing claudication pain (Hirsch, et al, 
1997),.  In contrast, exercise training alone has been found to increase time to the onset of 
claudication pain by 179% and the time to maximal claudication pain by 122% (Gardner 
and Poehlman, 1995).   
Cigarette smoking has long been known to be a contributor to vascular disease, 
with PAD being no exception (Lindgarde et al., 1989). The 5-year mortality rate for 
persons with PAD who continue to smoke is approximately 40-50%, similar to rates 
observed with many common cancers (Hirsch et al., 1997). In addition to increasing 
mortality, cigarette smoking is linked to increases in morbidity from PAD, such as 
progression from asymptomatic PAD to stable claudication, conversion of stable 
claudication to rest pain, increasing failure rate of limb bypass grafts and limb 
angioplasty, and increasing amputation rate (Fahey, 1999).   
In light of what is known about the benefits of regular exercise training and 
smoking cessation for patients with claudication, the purpose of this article is four-fold.  
First, the principles of exercise training in healthy adults, and in those who suffer from 
claudication will be discussed; second, the most current guideline for smoking cessation 
interventions will be presented.  Third, the most recent literature related to PAD, exercise 
training, and smoking cessation will be reviewed; and fourth, a case study of a patient 
with PAD who attempted to begin a regular walking program and quit smoking will be  
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presented.  It is our hope that this information will help health care professionals present  
current and accurate information to their patients who suffer from PAD, address the 
difficulties in lifestyle change, and intervene effectively.     
2.1  PRINCIPLES OF EXERCISE TRAINING 
Healthy Adults 
 The major objective in exercise training is to facilitate biologic adaptations that 
improve performance of specific tasks.  Successful achievement of these adaptations 
requires adherence to carefully planned exercise programs, with attention focused on 
factors such as frequency of workouts per day or week, duration of exercise sessions, 
intensity, type (mode) of exercise, and rest intervals (ACSM, 2000).   Although these 
factors vary depending on the performance goal, there are several basic principles of 
physiologic conditioning: 1) the overload principle, 2) the specificity principle, 3) the 
individual differences principles, and 4) the reversibility principle (ACSM, 2000). 
 The overload principle states that for a muscle or physiological system to improve 
its function, it must be worked at a load beyond which it is normally accustomed.  This 
involves exercising at a frequency, intensity, and/or duration that is greater than normal 
in order to achieve a training effect.  In addition, significant health-related benefits can be 
achieved by a given amount of overload, without necessarily improving cardiovascular 
fitness.  This concept is reflected in the exercise recommendation from the Centers for 
Disease Control and Prevention and the American College of Sports Medicine to 
accumulate 30 minutes or more of moderate intensity exercise on most days of the week  
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(Pate, Pratt, Blair et al., 1995).  This level of physical activity is considered minimal for  
health benefits, but not as effective for improving cardiorespiratory fitness as the more 
traditional exercise prescription (ACSM, 1990). 
 The specificity principle refers to the specific adaptations in the metabolic and 
physiologic systems that occur depending on the type of overload applied.  For example, 
a strength training regimen produces strength adaptations in the specific muscles 
involved, while an aerobic or cardiovascular exercise program produces adaptations in 
aerobic metabolism and in the cardiorespiratory system.  There is limited aerobic 
improvement derived from strength training, and vice versa (Hurley, Seals, Ehsani et al., 
1984).   Specificity is also demonstrated within anaerobic (e.g., strength training) and 
aerobic training.  For example, swim training produces significant improvements in 
swimming endurance, but minimal improvements in running endurance (Magel, 
McArdle, Toner et al., 1975).  In addition, overloading a specific muscle produces local 
changes that facilitate both oxygen transport and utilization (Green, Jones, Ball-Burnett, 
Farrance, and Ranney, 1995). These changes include an increase in the muscle oxidative 
potential, increased microcirculation, and increased cardiac output (ACSM, 2000; Green, 
et al., 1995).   
 The individual differences principle refers to the many individual variations that 
contribute to the training response.  For example, the level of fitness at the beginning of 
an exercise program will influence potential changes in fitness at the end of the program, 
with greater relative changes possible for someone initially low in fitness.  In addition, 
age, weight, history of past exercise, and comorbid illness, among many other things, will 
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influence an individuals response to any given type of exercise.  It is best to remember  
that training benefits are optimized when programs are individualized to each participant, 
and their personal exercise capacities are taken into consideration (ACSM, 2000).   
 Finally, the reversibility principle states that detraining occurs rapidly when a 
person stops exercising.  Significant reductions in both metabolic characteristics and  
exercise capacity can begin in only 1 or 2 weeks, and many of the training benefits are  
lost within several months (McArdle, Katch, and Katch, 1996).   Ultimately, it is 
important to remember that even for highly trained athletes, the benefits derived from 
many years of regular exercise can be reversed in a very short period of time. Application 
of these four principles of exercise training will result in several physiological 
adaptations (see Table 1.1).  Both the cardiovascular changes (e.g. increased stroke 
volume), and the local changes (e.g. increased capillary density and muscle oxidative 
capacity) work together to improve overall aerobic capacity and endurance.  For example, 
over time, as stroke volume, cardiac output, and plasma volume increase, more 
oxygenated blood is available for the exercising muscle.  As capillary density increases, 
the exercising muscle can receive more oxygenated blood.  As oxidative capacity 
improves, the exercising muscle can take up and use more oxygen.  Cumulatively, this 
change is represented by VO2max, or maximum oxygen uptake.  Maximum oxygen uptake 
refers to the maximum amount of oxygen that can be taken up and used by the muscles.  
In addition, not only is resting heart rate decreased, but heart rate is lower at any given 
work load (e.g., an untrained individual could have a heart rate of 150 beats/minute while 
running at 5 mph, but after training his or her heart rate might only be 130 beats/minute 
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running at the same speed).   The combination of enhanced oxygen transport and  
utilization, and decreased heart rate from aerobic training results in greater endurance, 
better exercise tolerance, and less fatigue. 
 Finally, when discussing exercise training from the standpoint of encouraging 
others to begin a regular exercise program, determinants of exercise must be addressed. 
The term exercise determinant refers to factors that mediate or influence level of 
activity.  These determinants can include characteristics of the person, of the 
environment, or of the physical activity (Buckworth, 2000).  Some personal determinants 
that positively correlate with higher levels of physical activity are sex (men), age 
(younger), education (more), race (non-Hispanic whites), and job (white collar).  Some 
modifiable determinants of exercise behavior include self-motivation, intention, self-
schemata (see yourself as an exerciser), self-efficacy (confidence in the ability to engage 
in an activity), and enjoyment of exercise (Dishman and Buckworth, 1996).  
Environmental influences include social support (stronger for women), and objectively 
measured access to facilities (physically close to the exercise location) (Buckworth, 
2000).  Characteristics of exercise itself that are exercise determinants are intensity 
(better for lower intensities) and mode of exercise (Buckworth, 2000).  Although a 
change in an exercise determinant (e.g. mode of exercise) does not guarantee a 
participants successful initiation and maintenance of exercise, it certainly enhances the 
probability of success.  As a result, it is worthwhile for clinicians to assess their patients 
exercise determinants. 
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Patients with Claudication 
The underlying pathophysiology of claudication involves tissue ischemia from 
decreased peripheral blood flow and oxygenation.  Therefore, exercise testing is a 
commonly used means of quantifying the extent to which the patient with claudication is 
disabled by his/her disease.  Because the pain of claudication is predictable and 
reproducible, a patient will be asked to walk on a treadmill at a standardized speed and 
grade (usually about 1.5 mph at a 10% grade).  During the test, patients may be asked to  
indicate when claudication begins (claudication pain time), and exercise is stopped when 
disabling claudication occurs (maximal walking time).  In addition, ankle pressures 
(measured over the dosalis pedis or posterior tibial artery) are recorded before and after 
exercise.  Normally, arterial flow increases in the extremity being exercised.  However, in 
those with arterial occlusions, flow decreases distal to the stenosis, and pressures after 
exercise drop proportionally with the severity of the disease (Fahey, 1999).  Because 
exercise training is known to increase claudication pain time and maximal walking time, 
one would assume that in some capacity, lower extremity blood flow is improved with 
exercise training, and by definition, peripheral pressures during and after exercise are 
improved.  However, this is not the case as lower extremity blood flow has been found to 
either remain unchanged or minimally improve after routine exercise training (Patterson, 
et al., 1997; Tan, de Cossart, and Edwards, 2000).   
The physiologic changes associated with exercise training in the PAD patient are 
the same as those seen in the healthy adult.  However, it is important to remember that 
because of their symptom-limiting disability, the person with claudication may not be  
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able to begin exercise at the same intensity as that of the healthy adult, and therefore may 
see an attenuation of their physiological adaptations, particularly changes in heart rate, 
stroke volume, and cardiac output.  However, even at lower intensity levels, PAD 
patients still experience improvements in claudication pain time and maximal walking 
without a correlating cardiopulmonary improvement (Ruell, Imperial, Bonar, Thursby, 
and Gass, 1984).  This improvement seems to be a result of peripheral factors such as 
changes locally in oxidative capacity and oxygen utilization, increased capillary density, 
changes in hemoglobin oxygen affinity, normalization of plasma viscosity, and 
economization of walking (Ernst and Matrai, 1987).   
Recently, twenty-three patients with claudication completed a 3-month 
unsupervised exercise program of walking 1 hour each day to the claudicating limit, 5 
days per week (Tan et al., 2000).   Pre and post exercise training, measures were taken 
during or after a standardized walking test to determine changes in maximal walking 
time, common femoral artery flow, oxygen uptake during exercise, plasma viscosity, total 
cholesterol with high-density lipoprotein (HDL) and low-density lipoprotein (LDL), 
triglycerides, exercise heart rate, and resting heart rate.  Although maximal walking time 
significantly increased (82%), there were no significant changes in femoral artery blood 
flow, plasma viscosity, LDL, triglycerides, or resting heart rate.  However, oxygen uptake 
and heart rate both significantly decreased during the standardized walking test, along 
with a significant drop in total cholesterol post training.  The changes in exercise oxygen 
uptake and heart rate could have been an indication of improved physical fitness, or  
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possibly an economization of walking.   In summary, the exact mechanism by which 
PAD patients improve their walking time by regular exercise training is not completely 
known.   
The principles of exercise training are effectively the same for healthy adults and 
patients with claudication.  First, the exercise must provide adequate overload to the 
affected muscles (intensity, frequency, and duration); the type of exercise must be 
specific to the type of improvement desired (walking exercise improves walking 
performance); the program of exercise must be individualized to account for personal 
preferences, degree of physical fitness, and extent of disability; and it must be maintained  
over a lifetime for the patient to see long term benefits.  Finally, because of their 
symptom-limiting disability, patients with claudication usually will need to begin with up  
to 20 minutes of interval exercise (walk-rest-walk-rest) and work up to 30-45 minutes of 
continuous exercise.  In addition, PAD patients may need to be assured that their 
claudication will not cause any physical damage despite the physical discomfort they 
feel. 
2.2  PRINCIPLES OF SMOKING CESSATION 
Tobacco use has been termed the agent most responsible for avoidable illness and 
death (Fiore, Bailey, Cohen et al., 2000). Tobacco use is the single most important cause 
of PAD (Ekers and Hirsch, 1999).  In 1996, the US Department of Health and Human 
Services published a clinical practice guideline for developing smoking cessation 
programs based on a meta-analysis of all available tobacco related literature.  This 
publication has been updated, and is entitled Treating Tobacco Use and Dependence  
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(Fiore et al., 2000).  Since 1994, an additional 3000 articles related to tobacco 
dependence have been published, and the new guideline reflects the latest, effective 
clinical treatments for tobacco dependence. 
 More than one-third of current smokers report never having been asked about 
their smoking status or urged to quit (Thorndike, Rigotti, Stafford, and Singer, 1998).  
Thus, the first step in treating tobacco use and dependence is to identify tobacco users.  
Every patient should be screened for tobacco use, and this screening will result in four 
possible responses: 1) the patient uses tobacco and is now willing to make a quit attempt; 
2) the patient uses tobacco but is not now willing to make a quit attempt; 3) the patient 
once used tobacco but has since quit; and 4) the patient never regularly used tobacco.  
The clinical practice guideline is organized to help clinicians develop simple, effective 
interventions for all patients (Fiore et al., 2000). 
Healthy Adults 
 Smoking behavior is influenced by pharmacological, psychological, social, and 
environmental factors. The powerful pharmacological reinforcement associated with 
smoking (a combination of euphoria and sedation) leads to the strong psychological 
dependence reported by smokers  (USDHHS, 1988; Shiffman, 1979).  The subsequent 
alleviation of negative affective symptoms such as tension, anxiety, boredom, and 
irritability lead to a continuation of the smoking behavior (Shiffman, 1979). Therefore, 
assessment of the patient's willingness to quit is essential.  For the patient willing to quit, 
the five major steps to intervention should be employed (see Table 1.2).  Once the  
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assessment is completed, strong advice to quit tobacco use should be given.  This should  
be clear, strong, and personalized, and might include a statement such as  
As your clinician, I need you to know that quitting smoking is the most 
important thing you can do to protect your health now and in the future.  The 
clinic staff and I will help you (Fiore et al., 2000, p 28). 
   
The third step, which includes assessing a patients willingness to quit tobacco use will 
determine the type of intervention offered.  Aiding the patient in quitting will at the very 
least include helping the patient with a quit plan, providing practical counseling, 
providing social support during treatment, helping the patient obtain social support after 
treatment, recommending the use of approved pharmacotherapy, and providing 
supplemental materials (See Table 1.3).  Finally, scheduled follow-up should be  
conducted, either by telephone or in person.  Contact should be made soon after the quit 
date, and the patient should be encouraged to continue with their plan. 
Since the 1996 Guideline was published, extensive research has been conducted 
regarding the use of pharmacotherapies to aid in smoking cessation.  Recommended 
pharmacotherapies help patients overcome their physical addiction, but do not alter the 
psychological, social, or environmental factors that influence smoking behavior.  
Therefore, these pharmacotherapies are intended as an adjunct to behavioral counseling 
and follow-up (Fiore et al., 2000).  The current guideline recommends several 
pharmacotherapies as first-line medications, as they have been found to be safe and 
effective for tobacco dependence treatment, and have been approved by the US Food and 
Drug Administration for this use (see Table 1.4).   
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Bupropion, an oral neural reuptake inhibitor, has been found to double tobacco 
cessation rates compared to placebo (Fiore et al., 2000).  Those taking Bupropion should  
be informed that the medication is begun prior to their quit date, and that they may lose 
their desire to smoke or spontaneously reduce the amount they smoke.  In addition, if 
insomnia occurs, taking the evening dose a little earlier in the day may help.  Nicotine 
gum has been found to improve long-term abstinence rates by approximately 30-80% as 
compared to placebo (Fiore et al., 2000).  Patient education should include information 
about 1) chewing technique: chew slowly until minty taste emerges, then park the gum 
between the cheek and the gum; 2) absorption: avoid eating or drinking anything but 
water 15 minutes before and during chewing; and 3) scheduling: chew one piece every 1-
2 hours.  The nicotine inhaler can as much as double cessation rates compared to placebo 
(Fiore et al., 2000).  Specific instructions to patients should include avoiding eating or 
drinking 15 minutes before inhalation to promote absorption; keeping the cartridge at 
temperatures above 40 degrees F to promote delivery of nicotine; and using the inhaler 
for up to 6 months with gradual reduction in frequency of use over the last 6-12 weeks of 
treatment.  Nicotine nasal spray more than doubles long-term abstinence rates when 
compared to a placebo spray (Fiore et al., 2000).  Patients should be instructed not to 
sniff, swallow, or inhale through the nose while administering doses as this increases 
irritating effects.  Finally, the nicotine patch approximately doubles long-term abstinence 
rates over those produced by placebo interventions (Fiore et al., 2000).  Instruct patients 
to apply the patch first thing in the morning, over a relatively hairless portion of the skin.   
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For patients who are unwilling to quit tobacco use, the motivation to quit should 
be promoted.  In this case, the 5 Rs are helpful to remember.  First, the relevance of 
quitting should be discussed (e.g. health concerns).  Next, the risks of smoking should be  
identified (e.g. progression of PAD).  Third, the rewards of quitting should be stressed 
(e.g. improved health, feel better about yourself).  Fourth, roadblocks to quitting should 
be identified (e.g. fear of failure or lack of support).  And finally, repetition by the 
clinician is keythe motivational intervention should be repeated every time an 
unmotivated client is seen (Fiore et al., 2000).   
 For the patient who has recently quit, the clinician should focus on preventing 
relapse.  This intervention focuses on the benefits derived from cessation, any success 
that patient has had in quitting, and discussion of the problems encountered or anticipated 
threats to maintaining abstinence.  Meanwhile, patients should be encouraged and 
congratulated to continue with their tobacco abstinence. 
For those clinicians who have the opportunity to provide a more intensive 
intervention than that discussed above, it is important to note that there is a strong dose-
response relationship between counseling intensity and cessation success (Fiore et al., 
2000). For example, patients receiving 31 to 90 minutes of counseling are 3 times as 
likely to succeed in smoking cessation compared to the patient who receives no 
counseling.  Even the person who receives 1 to 3 minutes of tobacco cessation counseling 
is 1.4 times more likely to quit as the person who does not receive counseling.  There are 
several critical features of a more intensive intervention.  First, multiple types of 
clinicians are effective and should be used.  This could include health care providers from 
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different disciplines providing education at different times.  Next, the number of sessions 
with each patient should equal 4 or greater, each session length should be 10 minutes or 
more, and total contact time should be longer than 30 minutes.  Third, individual or group  
counseling may be used, and telephone counseling is also effective.  Fourth, as with less 
intensive therapies, pharmacotherapy should be encouraged.  Finally, counseling and 
behavioral therapies should include problem solving/skills training, and intra-treatment 
and extra-treatment social support.   
Patients with Claudication 
 One important question regarding quitting smoking is whether patients with PAD 
should receive the same cessation interventions as other populations.  Unfortunately, this 
question has not been clearly answered in the literature, but there does not seem to be any 
evidence to the contrary.  One factor to consider is that most patients with claudication 
are 50 years or older, and therefore smoking cessation strategies aimed at older adults 
would be appropriate (Rockson and Cooke, 1998).  Fortunately, smoking cessation 
treatments developed by the guideline outlined above have been found to be effective 
with older adults (Fiore et al., 2000).   
Another consideration is the use of pharmacotherapies to aid in smoking cessation 
with PAD patients.  The incidence of cardiovascular disease is significantly greater in the 
PAD population than the general adult population.  Soon after the nicotine patch was 
released, the media reported a possible link between the use of this medication and 
cardiovascular risk.  Since then, researchers studying this question have found no 
association between the nicotine patch and cardiovascular deaths (Fiore et al., 2000). As a 
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result, nicotine replacement can be safely recommended for use with PAD patients.  
However, many clinicians still hesitate to recommend nicotine replacement to patients 
with claudication because of the peripheral vasoconstrictive effects of nicotine.  Although  
the side effects of nicotine replacement must be considered, the short-term effects of 
nicotine replacement versus the long-term effects of continued smoking should also be 
compared.  If nicotine replacement is considered a risk, then non-nicotine 
pharmacotherapies (e.g. Bupropion) can be recommended.   
2.3  REVIEW OF RECENT LITERATURE 
Exercise Training and PAD 
The original recommendation for using routine exercise to treat intermittent 
claudication came from Erb in 1898 (Tan et al., 2000).  Since then, many controlled trials 
have studied the effects of exercise training in patients with PAD.  As a result, several 
meta-analyses have been conducted, with agreement among researchers that the outcome 
of a regular exercise program is good and that the improvement in exercise time is 
generally greater than 100% (Gardner and Poehlman, 1995; Robeer, Brandsma, van den 
Heuvel, Smit, Oostendorp, and Wittens, 1998).  Recently, a meta-analysis of 21 exercise 
related research studies identified very specifically the predictors of change in 
claudication pain distances after participating in a regular exercise program.  The three 
exercise program components that were independently related to improvement in walking 
time were: 1) incorporating near maximal claudication pain end point (near maximum 
walk time) during the exercise training program, 2) at least 26 weeks of exercise, 3 
times/week for at least 30 minutes/session, and 3) walking as the mode of exercise 
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(Gardner and Poehlman, 1995).  Since the publication of these meta analyses, other 
experimental studies have been conducted to assess the beneficial effects of exercise  
training, and similar conclusions were drawn (Gibellini, Fanello, Bardile, Salerno, and 
Aloi, 2000).   
One component of a regular exercise program that has been addressed is the value 
of supervision versus no supervision.  In a randomly controlled trial comparing 
supervised and home-based exercise, both groups improved (p < .001) in claudication 
pain time and maximal walking time at the completion of the 12-week program and 
maintained the improvement at 6 months (Patterson et al., 1997).  However, the 
supervised exercise group did have a significantly (p < .004) greater increase in their 6-
month claudication pain time and maximal walking time than the home-based exercise 
group (Patterson et al., 1997).  Others have seen similar benefits derived from supervised 
exercise (Gardner and Poehlman, 1995).  Even so, it is important to remember that if 
patients with claudication adhere to a home-based exercise program, significant benefits 
can be derived (Patterson et al., 1997).   Unfortunately, only about 50% of individuals 
who participate in limited-duration preventive or rehabilitative programs continue beyond 
the 6-month mark (Burke and Dunbar-Jacob, 1995).  This could be a result of the 
exercise determinants that were previously discussed, such as social support, proximity 
to the exercise facility, and type of exercise.  Adherence-enhancing interventions have 
been identified and include educational strategies that enable patients to implement and 
maintain the regimen, and behavioral strategies such as goal setting and contracting  
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(Burke and Dunbar-Jacob, 1995).   While these strategies have been used successfully 
with healthy adult populations, no such strategies have been used explicitly with PAD 
patients (Calfas, Long, Sallis, Wooten, Pratt, and Patrick, 1996).   
Researchers have shown that exercise training is effective in increasing 
claudication pain time and maximal walking time.  However, what is not clear is the  
relationship between walking time and quality of life in patients with PAD (Tan et al., 
2000).  Several researchers have investigated the differences in quality of life between 
healthy adults and patients with claudication (Barletta, Perna, Sabba, Catalano, OBoyle, 
and Brevetti, 1996; Khaira, Hanger, and Shearman, 1996; Bauman and Arthur, 1997).  
While two of the three reports indicated that quality of life is significantly affected by 
decreased functional capacity (Khaira et al., 1996; Bauman and Arthur, 1997), the third 
did not find a correlation between treadmill performance and social or emotional 
function, but did find a correlation (small, but significant) between treadmill performance 
and physical function (Barletta et al., 1996). In two other studies, quality of life was 
measured using the SF-36 (MOS) (Patterson et al., 1997) and the SF-20 (MOS) 
(Regensteiner, Steiner, and Hiatt, 1996) at three and six months after the initiation of an 
exercise program. For all exercise subjects, treadmill performance significantly 
improved, in addition to significant improvements in the Physical function subscale 
(Patterson et al., 1997; Regensteiner et al., 1996), Bodily pain subscale (Patterson et al., 
1997), and the Physical composite score (Patterson et al., 1997).  Degree of supervision 
did not seem to make a difference as some of the subjects were involved in home-based 
exercise (Patterson et al., 1997). While there is a paucity of literature on the relationship 
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between PAD and quality of life, there is evidence that at least the physical function 
component of quality of life seems to be improved with regular exercise training.   
Smoking and PAD 
Despite the fact that smoking has been identified as the most significant factor 
contributing to the onset and progression of PAD, most information on the effects of  
smoking cessation is from natural history studies of persons with intermittent 
claudication (Radack and Wyderski, 1990).  Despite several methodological problems 
associated with the majority of the natural history studies in PAD, two common themes 
have been identified: 1) fewer than 50% of patients reported smoking cessation despite 
participation in a supervised smoking cessation program, and 2) discontinuation or 
reduction of cigarette smoking as reported by subjects with intermittent claudication was 
associated subsequently with a reduced frequency of peripheral vascular complications 
(Radack and Wyderski, 1990).  In addition, smokers have been found to have more 
debilitating claudication symptoms compared to non smokers (Gardner, 1996). These 
symptoms may include lower resting ankle pressures and more severe claudication pain.    
In one experimental study conducted with persons with PAD, a smoking cessation 
program was implemented during visits to a peripheral vascular clinic (Power, Brown, 
and Makin, 1992).  A health promotion officer provided a one-time only smoking 
cessation counseling session for 30-45 minutes, yielding no significant differences 
between the control and experimental groups on smoking cessation rates at one and six 
months.  These authors concluded that their lack of significant findings could have been a  
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result of their older population with high smoking rates.  They recommended smoking 
cessation counseling that emphasizes personal benefits of quitting and employing 
multiple methods tailored to the individual. 
Despite the paucity of literature on successful smoking cessation interventions 
with PAD patients, it is realistic to expect patients with claudication to stop smoking.  For 
example, only 30-40% of individuals with stable claudication are current smokers,  
although most of these individuals smoked in their past (Hirsch et al., 1997).  The higher 
rate of current smokers in vascular clinics reflects the effect of tobacco on the 
acceleration of thrombosis and athersclerosis (Hirsch et al., 1997).  These data provide 
clinicians with the impetus to develop effective and pertinent interventions for their 
patients who continue to smoke. 
2.4  SUMMARY 
Exercise training and smoking cessation are the cornerstone of claudication 
management.  The critical components of any training program aimed at treating PAD 
must include: exercise of adequate duration (at least 26 weeks, 3 times/week, 30 minutes 
each session); proper exercise mode (walking); and appropriate exercise intensity 
(walking to near maximum pain before stopping to rest).  In addition, determinants of 
exercise behavior must be assessed in order to promote long-term maintenance of the 
behavior.  Before developing an exercise prescription for patients with claudication, it is 
important to determine the patient's attitude toward exercise, the attitude of their spouse 
or significant other toward exercise, the source of their motivation to exercise, and their 
belief in their ability to begin and adhere to an exercise program.  Clinicians also must 
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discuss the symptom-limiting nature of PAD, and that interval training is the best way for 
patients with claudication to begin a regular walking program.  Finally, although a  
supervised exercise program is an effective way to manage claudication, the resources 
and/or the time is not always available for such an undertaking.  For those patients unable 
or unwilling to attend a supervised program, clinicians can discuss home-based exercise 
using adherence enhancing strategies such as goal setting and contracting.  
Despite the fact that cigarette smoking is the most significant risk factor in 
developing PAD and its subsequent progression, almost half of patients with claudication 
who continue to smoke do not contribute their disease to smoking (Bloom, Stevick, and 
Lennon, 1990).  In fact, most of these same smokers do not plan to stop smoking until 
serious health and disease problems are manifested (Bloom et al., 1990).  Clinicians 
should not despair from this information as the majority of patients with claudication are 
former smokers.  However, assessing the patient's smoking status and readiness to quit is 
essential with every PAD patient.  Current smokers must receive a clear, strong message 
in favor of quitting from their clinician.  If the patient is ready to quit, in addition to 
encouraging the use of pharmacotherapy, develop a written plan for quitting, along with 
providing and helping the patient to find social support, and providing clinician follow-
up.  For the patient who is unwilling to quit smoking, promote the motivation to quit--
perhaps by providing accurate information regarding the relationship between smoking 
and PAD. 
In an effort to apply the principles discussed in this paper, a case study describing 
the efforts of one patient with claudication to quit smoking and begin exercising is 
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presented.  This individual attended a 12-week class presenting the benefits of smoking 
cessation and exercise adoption.  In addition, information about other pertinent topics for  
PAD patients was presented, including foot care, hypertension, heart disease, and 
nutrition. 
2.5  CASE STUDY 
K.L. is a 62-year-old Caucasian male with a 10-year history of stable claudication 
and a 42-year one pack per day smoking history.  He works at a desk most of the day, and 
at our initial visit he was not exercising at all, but wanted to begin a regular walking 
program.   He also stated he wanted to quit smoking, but did not think he was quite ready 
to make that change.  His wife is a smoker who has no intention of quitting, but would be 
interested in starting to exercise with K. L.  Upon initial assessment, K. L. stated he could 
walk about one block on level ground before claudication in both calves would force him 
to stop.  He had been taking Cilostazol (Pletal) for several months with minimal 
subjective improvement in his claudication pain distance.  Additional assessment 
included questioning him about exercise self-efficacy (confidence in his ability to 
exercise), which was determined to be quite high.  In addition, his level of nicotine 
addiction was addressed.  His level of psychological addiction seemed to be greater than 
his level of physical addiction as evidenced by his statement that he could go all day 
without smoking, but once he got home and faced some personal stress, he would feel the 
need for a cigarette.  Finally, his actual exercise performance was assessed.  During a 
standardized treadmill walking test, K. L. experienced initial claudication at 2 minutes 46 
seconds, and maximal walking time was measured at 8 minutes 13 seconds. 
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Once the initial assessment was complete, K. L. began to attend a 12-week, one 
hour/week, small group counseling session where principles of exercise adoption and 
smoking cessation were discussed.  Principles of exercise training were presented (e.g. 
the need for overload to specific muscles), and an individualized exercise program was  
designed for him based on what he felt he could do.  He decided to start out at 10 
minutes/day, 7 days/week of interval training, walking exercise.  K. L. also decided to 
buy a treadmill to help him adhere to his exercise program.  In addition, his progress was 
discussed on a weekly basis in the small group.  Over the 12 weeks of counseling, K. L. 
progressed to about 15 minutes/day of continuous exercise, but never was able to increase 
his daily exercise time to the recommended 30 minutes/day.  He stated his primary 
barrier to increasing his exercise time was a busy schedule.  Despite probing questions, 
we were never able to determine ways for him to find more time for exercise. 
Because K. L. had stated he was not quite ready to quit smoking, we worked on 
promoting his motivation to quit.  On a weekly basis, we focused on the benefits of 
quitting smoking, primarily by slowing the progression of his PAD.  On several 
occasions, he stated he wanted to make the commitment to quit smoking, but by the end 
of the 12-week program, he hadn't yet been able to so.  K. L. refused the use of 
pharmacotherapies to aid him in quitting.  He stated his major barrier to quitting was 
stress at home.  As a result, we talked extensively about alternative ways to handle stress. 
At the conclusion of the 12-week class, K. L. in conjunction with the other class 
members and the nurse facilitator, developed a contract for continuing exercise.  During a 
repeat of the standardized treadmill walking test, K. L. experienced initial claudication at 
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8 minutes 32 seconds, which was nearly a 5-minute improvement.  His maximal walking 
time increased to 10 minutes 40 seconds, which was greater than a 2-minute 
improvement.  In addition, he stated he stopped the exercise test primarily because of 
fatigue and shortness of breath rather than from claudication.   
For three months after he completed the 12-week program, K. L. was called every 
two weeks to promote adherence to his exercise regimen.  However, after only about 2 
months, K. L. was diagnosed with carotid artery disease, and underwent a carotid 
endarterectomy.  K. L. stated that he felt this diagnosis was serious enough to motivate 
him to quit smoking.  From the time of his surgery, K. L. has not smoked (about 2 
months), and within about a week postoperatively, K. L. resumed his exercise regimen of 
15 minutes walking/day.  In a telephone conversation, K. L. stated he has never felt 
better, and is confident in his ability to continue exercising and to abstain from smoking. 
Two lessons learned from working with K. L. include: 1) the importance of 
partnering with patients to develop plans for exercise adoption and smoking cessation, 
and 2) many smokers do indeed wait until a "critical health event" has occurred before 
they are ready to quit smoking.  As clinicians, our role involves working with patients to 
provide accurate information and resources to facilitate exercise adoption.  In addition, 
even when a patient states he or she is not ready to quit smoking, we must continue to 
promote the motivation to quit, so that when they are finally ready, they will be 
empowered to make the change successfully.  
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Physiologic variable Change after exercise training 
Vo2max, mL/kg/min Increased 
Cardiac output, L/min Increased 
Stroke volume, mL/beat Increased 
Heart rate, beats/min Decreased 
Plasma volume, L Increased 
Capillary density, cap/mm Increased 
Oxidative enzyme capacity Increased 
 
Source: McArdle, Katch, and Katch, 1996 
 
Table 2.1: Physiologic Consequences of Exercise Training 
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Ask about Tobacco use 
Advise to quit 
Assess willingness to make a quit attempt 
Assist in quit attempt 
Arrange follow-up 
 
Source: Fiore et al., 2000 
 
Table 2.2: A guide to the brief intervention 
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Strategy Specific steps 
Help the patient 
develop a quit plan. 
Set a quit datewithin 2 weeks.  
Tell others about quitting  
Anticipate difficulties in planned quit attempt 
Remove tobacco products from your environment  
 
Provide problem 
solving and 
behavioral training). 
AbstinenceTotal abstinence is the goal.  
Past quit experienceReview past quit attempts what 
helped? What did not help? 
Anticipate challenges in upcoming quit attemptDiscuss 
techniques to  overcome them.  
Alcoholconsider limiting/abstaining from alcohol while 
quitting.  
Other smokers in the householdencourage housemates to 
quit or not smoke in their presence. 
 
As a clinician, 
provide social 
support. 
 
Demonstrate your support during this difficult change. 
 
Help patient identify 
support persons. 
Help patient list persons (family, friends, co-workers) who 
can provide social support during the quit attempt.  
 
Recommend use of 
approved tobacco 
treatment 
pharmacotherapy, 
except in special 
circumstances. 
Explain how these medications have improved smoking 
cessation success and reduced nicotine withdrawal 
symptoms.  
 
 
Provide additional 
print materials. 
SourcesFederal and nonprofit agencies, local/state health 
departments, or commercial providers.  
Review materials to meet your particular patients needs 
related to culture, educational level, and age appropriateness. 
Maintain a supply of materials and resources at every 
clinician's workstation. 
Source: Fiore et al., 2000 
Table 2.3: Assisting the patient to quit smoking 
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Drug name Dosage Availability Cost/day 
Bupropion 150 mg qAM for 3d; increase 
to 150 mg BID 
 
Zyban
prescription only 
 
$3.33 
Nicotine gum 2mg/piece for those smoking 
<25 cigarettes/day; otherwise 
use 4mg/piece; for up to 12 
weeks, no more than 24 
pieces/day 
 
Nicorette, Nicorette 
Mintover the 
counter only 
$6.25 for 10, 
2mg pieces 
$6.87 for 10, 
4mg pieces 
Nicotine 
inhaler 
4mg of nicotine is delivered 
over 80 inhalations; 
recommended 6-16 
cartridges/day, for up to 6 
months. 
 
Nicotrol inhaler
prescription only 
$10.94 for 10 
cartridges 
Nicotine nasal 
spray 
1 dose = 0.5 mg delivery to 
each nostril; 1-2 doses/hour.  
Maximum of 40 doses/day (5 
doses/hour).  Each bottle 
contains about 100 doses 
 
Nicotrol NS
prescription only 
$5.40 for 12 
doses 
Nicotine patch Varies from 7mg  21 
mg/patch.  Individualize 
treatment to patient.  
Typically, patients start at a 21 
mg patch /day for 4 weeks, 
followed by 14 mg/day for 2 
weeks, and ending with 7 
mg/day for 2 weeks. 
Nicoderm CQ, 
Nicotrol, generic
over the counter 
Nicotine patches 
(various doses)--
prescription 
$4 - $4.50 
(brand name) 
 
Source: Fiore et al., 2000 
 
Table 2.4: Information on first-line pharmacotherapies to aid in smoking cessation 
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CHAPTER 3 
 
THE TRANSTHEORETICAL MODEL, THE MODEL OF NICOTINE ADDICTION, 
AND EXERCISE DETERMINANTS AS THE BASE FOR DEVELOPING AN 
EXERCISE ADOPTION AND SMOKING CESSATION INTERVENTION 
Peripheral arterial disease (PAD) affects up to 20% of older adults in the general 
population (Fowkes, 1997; Stewart, et al., 2002).  Lower extremity PAD is a 
manifestaton of atherosclerotic plaque, resulting in claudication, which is defined as 
walking-induced pain in one or both legs relieved by rest (Fahey, 1999).  The treatment 
of this condition focuses on decreasing the functional impairment caused by symptoms of 
claudication, and treating the underlying systemic atherosclerosis in patients with 
claudication (Stewart et al., 2002).  Cigarette smoking and sedentary lifestyle are known 
risk factors for symptomatic PAD (Christman, et al, 2001).  Based on research, exercise 
training and smoking cessation have become the cornerstones of managing claudication.  
As a result, vascular nurses have a unique role to play in helping patients who suffer from 
lower extremity PAD manage their symptoms through life-style changes. 
 Regular aerobic exercise has long been known as an effective therapy for 
decreasing the functional impairment caused by symptoms of claudication (Rockson and 
Cooke, 1998).  Exercise training alone has been found to increase time to the onset of  
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claudication pain by 179% and the time to maximal claudication pain by 122% (Gardner 
and Poehlman, 1995).  While the improvement in claudication symptoms after exercise 
training are not completely understood, there is some research to support specific 
physiological, metabolic, and mechanical alterations which include formation of 
collateral vessels and increased blood flow to the affected muscle, changes in 
microcirculation and endothelial function, changes in muscle metabolism and oxygen 
extraction, and improved walking economy (Stewart et al., 2002).    For the claudicant, 
the overall improvement in functional capacity after smoking cessation is also 
documented and includes benefits such as increased exercise tolerance, maintaining or 
improving ankle pressures (versus a reduction in ankle pressures for those who continue 
to smoke), and decreased claudication symptoms (Quick and Cotton, 1982; Hirsch, et al, 
1997; Gardner, 1996).  In addition, there appears to be a progressive decline in free-living 
daily physical activity with greater levels of smoking exposure in PAD patients, primarily 
due to smoking-related impairments in ambulatory function and peripheral circulation 
(Gardner, Montgomery, Womack, and Killewich, 1999).  
 While the benefits of regular aerobic exercise and smoking cessation as a 
treatment for claudication have been widely reported, the reality of helping people 
change long-standing unhealthy behaviors is more complicated (Christman et al., 2001).  
Recently published articles have supported the argument that a supervised exercise 
program yields improvements in the pain free walking time of claudicants almost double 
that of home based exercise programs (Patterson et al., 1998; Degischer, Labs,  
Hochstrasser, Aschwanden, Tschoepl, and Jaeger, 2002).  Unfortunately, mean dropout 
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rates from supervised exercise programs reported around the world has remained at 
roughly 50% over the past 20 years (Dishman and Buckworth, 1996).  In addition, while 
natural history studies with PAD patients have shown the benefits of a "non smoking" 
state, intervention studies to help claudicants quit smoking have yielded non-significant 
findings (Power et al., 1992; Fowler et al., 2002).   
There is a paucity of literature regarding specific interventions to help claudicants 
adopt regular aerobic exercise and quit smoking, and in fact, none of these interventions 
have an identified theoretical base.  Oberst (1989) has stated that atheoretical 
interventions are little more than trial and error regarding what does and does not work.  
Comparatively, in studies where nurse researchers have used strong theoretical 
frameworks to guide program development, the results have substantially more impact on 
practice and subsequent research than is the case for atheoretical studies (Oberst, 1989).  
The purpose of this article then, is to describe the theoretical basis for a nurse-
implemented exercise adoption and smoking cessation educational program for persons 
with lower extremity PAD.  Details of the intervention protocol and outcomes are 
reported elsewhere (Chapter 4).  In order to develop a comprehensive program, three 
theoretical models were identified and utilized to develop this program: 1) the 
Transtheoretical Model, 2) nicotine addiction, 3) exercise determinants. Each model will 
be reviewed, followed by a description of how the model was used to develop and 
implement the intervention. 
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3.1  THEORETICAL MODELS 
Transtheoretical Model 
The Transtheoretical Model of Behavior Change (TTM) was first proposed in 
1977 by a practicing psychologist (Prochaska, 1977).  He had become interested in 
behavior change from experiences counseling people trying to change addictive 
behaviors.  Subsequently, he reviewed 18 different systems of psychotherapy and found 
similarities among them.  As a result, he proposed the use of a transtheoretical model 
(TTM) versus one isolated model of psychotherapy.  In addition, observations were made 
and interviews were conducted with people who had successfully changed an addictive 
behavior (smoking) on their own to try and determine how they achieved success.  A 
pattern of change consistently followed by successful changer began to emerge, and this 
process was named the stages of change (Prochaska and DiClemente, 1984).  The 
original model consisted of 4 stages: precontemplation, contemplation, action, and 
maintenance.  By the late 1980's researchers had identified a 5th stage called preparation, 
which preceded the action stage (Prochaska, Redding and Evers, 1997).   From the initial 
studies with smokers, the TTM has expanded in scope to include investigations with a 
broad range of behaviors including but not limited to eating disorders and obesity, AIDS 
prevention, sun exposure, and sedentary lifestyle (Prochaska, 1994).   
The core constructs of the TTM are stages of change, processes of change, 
decisional balance, and self-efficacy (Prochaska and Velicer, 1997).  As people change a 
behavior, the five stages of change through which they pass are precontemplation (no 
intention for change in the next 6 months), contemplation (intend to change in the next 6  
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months), preparation (intend to change in next 30 days), action (change has occurred in 
last 6 months), and maintenance (changed more than 6 months ago).  Movement through 
these stages occurs in a cyclical manner and many individuals make several attempts at 
behavior change before reaching maintenance (Prochaska, et al., 1997).   
The processes of change, which are the strategies used by people to move forward 
through the stages of change, have been refined from the original publication and involve 
10 cognitive/experiential and behavioral processes (Prochaska and DiClemente, 1983; 
Prochaska et al., 1997) (see Table 3.1).  Although there are no specific processes that are 
used to change different behaviors, there is a relationship between cognitive processes 
and the earlier stages of change, and behavioral processes and the later stages of change 
(Prochaska et al., 1997).   
Decisional balance reflects an individuals relative weighing of the pros (benefits) 
and the cons (consequences) of behavior change (Prochaska et al., 1997).  In the earlier 
stages of change the cons of changing outweigh the pros, thus decisional balance is low.  
However, as progression is made toward action, the pros of changing outweigh the cons 
and decisional balance becomes higher.  In fact, the construct of decisional balance is 
thought by some to be critical in predicting the success or failure of behavior change.  An 
increase in pros score by one standard deviation, and a decrease in cons score by 0.5 
standard deviation has been identified by Prochaska as a prerequisite to moving into the 
action stage of change (Prochaska et al., 1997).   
The construct of self-efficacy is the situation specific confidence to engage in a 
behavior with known outcomes (Bandura, 1991).  Confidence is the primary construct 
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and is related to the situation specific belief people have that they can cope with high-risk 
situations, such as exercising during inclement weather, or not smoking after eating 
(Prochaska et al., 1997).  Theoretically, as people pass from precontemplation to 
maintenance, self-efficacy increases linearly (Prochaska and DiClemente, 1984).   
The TTM and Exercise Adoption.  In the early 1990s, Marcus and others applied 
the TTM to exercise (Marcus, Selby, Niaura, and Rossi, 1992; Marcus and Simkin, 
1994).  Subsequent research has clarified that description of the stage and the definition 
of exercise has consequences for staging of behavior (Reed, Velicer, Prochaska, Rossi, 
and Marcus, 1997).  Although no particular definition of exercise has been advocated, 
longer, more complete definitions of exercise produce larger numbers of people in the 
early stages (precontemplation and contemplation), as opposed to the short definitions, 
which showed a higher percentage in the late stages (preparation and action) (Reed et al., 
1997).  These researchers also used the TTM to develop a questionnaire to measure the 
processes of change associated with exercise behavior (Marcus, Rossi, Selby, Niaura, and 
Abrams, 1992).   
The original ten processes of change are used during exercise adoption, the 
cognitive processes have been found to peak in the action stage, while behavioral 
processes have been reported to increase from preparation to action and then remain 
constant (Marcus, Pinto, Simkin, Audrain, and Taylor, 1994).  In an extensive review of 
the literature, Buxton and colleagues (1996) found that researchers have consistently 
found decisional balance to significantly differ between subjects in the different stages of  
exercise behavior change.  Generally, the reasons for not exercising tended to outweigh 
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the reasons for exercising for those in precontemplation and contemplation, while there 
was a balance of the pros and cons in preparation (Buxton, Wyse, and Mercer, 1996).  
For those in action and maintenance, the pros of exercising outweighed the perceived 
disadvantages of exercise (Buxton et al., 1996).   
Exercise self-efficacy is a widely studied construct, and has shown a consistent 
relationship with exercise stage, in addition to being one of the strongest predictors of 
present and future exercise behavior (McCauley and Blissmer, 2000; Buxton et al., 1996).  
Recently, investigators have confirmed a difference between those in the action and 
maintenance stages of exercise behavior according to maximal aerobic capacity (greater 
in maintenance), volume of exercise per week and number of months consistently active 
(higher in maintenance), decisional balance scores (higher pros score in maintenance 
than action), and 4 processes of change were different between stages (1 cognitive and 3 
behavioral) (Buckworth and Wallace, 2002). 
The TTM has been applied to interventions with healthy adults at both the 
community level, and in primary care settings (Marcus, Banspach, Lefebvre, Rossi, 
Carlton, and Abrams, 1992; Calfas, et al., 1996).   At the community level, the results of 
an exercise intervention utilizing pre-printed stage-specific materials revealed that 62% 
of the participants originally in contemplation became more active while 61% of the 
participants originally in preparation became more active (Marcus et al., 1992).   In 
primary care settings, the TTM has been used successfully to encourage exercise 
adoption utilizing 3 to 5 minutes of stage-specific physical activity counseling by the 
primary health care provider (physician or nurse practitioner) and one follow-up phone 
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call (Calfas et al., 1996).  At approximately 5  weeks post intervention, the subjects in the 
intervention group reported significantly (p < .05) more activity than those in the control 
group.  Neither of these studies assessed decisional balance or self-efficacy. 
The TTM and Smoking Cessation.  The TTM was originally developed by 
studying current smokers and successful ex-smokers (Prochaska et al., 1997; DiClemente 
and Prochaska, 1982).  As a result, the TTM is applicable to smoking cessation 
behaviors.  While the stages of change have been revised since the original four stages, 
the five current stages of smoking behavior have been found to have construct validity 
with a high level of reliability and stability (Spencer, et al., 2002).  In an extensive review 
of the literature, Spencer and colleagues identified criticism of the stages of change 
construction in that some say there are more than five stages of change.  Two descriptive 
cross-sectional studies of precontemplating smokers found significant differences 
between what they called immotives, who are not planning to quit within five years, 
and precontemplators, who are planning to quit within five years (Spencer et al., 2002).  
Recently, Prochaska and colleagues have addressed this issue by producing preliminary 
work on cluster subtypes within stages based on perceptions of well being, situational 
temptation, and tobacco use.  In addition to the stages of smoking behavior, there are 10 
processes of change utilized during movement between stages, with the 
cognitive/experiential processes used more frequently during the early stages, and the 
behavioral processes used more frequently during the later stages (Prochaska and Velicer,  
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1997).  Finally, smoking self-efficacy has been found to peak at 18 months after quitting, 
with the temptation component of self-efficacy for smoking leveling out at approximately 
36 months after quitting (Prochaska and DiClemente, 1984).   
The TTM has been used in several smoking cessation intervention studies.  In one 
large scale intervention study, current smokers were divided into four groups; three 
groups with varying types of stage matched interventions, and one group with a standard 
program (Prochaska, et al., 1993).  Those in the stage matched intervention groups had 
18-25% cessation rates at the 18-month follow-up compared to a 10% cessation rate in 
the control group. In another study, a smoking cessation manual was developed and used 
in an intervention targeted toward smokers over 50 years of age (Morgan, Noll, Orleans, 
Rimer, Amfoh, and Bonney, 1996).  The Clear Horizons smoking cessation manual was 
developed based on the TTM, and emerged after conducting focus groups with older 
adults, a national survey, and a pilot test (Rimer and Orleans, 1994).  Using a sample of 
659 smokers ages 50-74, a randomized controlled trial compared usual care (control 
group) with physician-delivered brief quit-smoking advice and counseling supplemented 
by the Clear Horizons manual (Morgan et al., 1996).  At 6-month follow-up, the quit 
rates in the intervention group were twice that of the control group (15.4% versus 8.1%).  
This study provides evidence that even a one-time admonition to quit smoking is 
beneficial when combined with a theory-based stage-specific manual.  Although there is 
a growing body of well designed studies demonstrating stage-matched interventions to be 
more effective than non-stage matched interventions, there are also eight non-stage  
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matched interventions that also show forward stage progression (Spencer, et al., 2002).   
However, in their review of the related literature, Spencer et al. stated that as a whole, the 
non-stage matched interventions were not well-designed (2002).   
Although the TTM has been successful in helping to develop smoking cessation 
interventions, some researchers dispute its predictive ability.  In 1999, Herzog and 
colleagues reported that with their sample of smokers, cross-sectional results replicated 
previous studies with virtually all the processes of change and the cons of smoking 
increasing in linear fashion from precontemplation to preparation, and the pros of 
smoking decreasing.  However, the baseline processes of change and the pros and cons of 
smoking failed to predict progressive stage movements at either the 1 or the 2-year 
follow-ups (Herzog, Abrams, Emmons, Linnan, and Shadel, 1999).  The ability of the 
TTM to predict movement toward successful change has been questioned by others.  In 
1996, Farkas et al. compared the nicotine addiction model to the TTM to predict smoking 
cessation, and found that when stage membership was combined with baseline measure 
of addiction including smoking behaviors and quitting history, the stage of change was 
not a significant predictor of future cessation.  This finding is not particularly surprising, 
since the TTM is a comprehensive model, and involves more than just the stages of 
change. 
Nicotine Addiction 
Nicotine in tobacco smoke is rapidly absorbed in the large surface area of small 
airways and alveoli of the lung (Benowitz, Porchet, and Jacob, 1990).  Nicotine has a 
relatively short half-life of about 2 hours before it is converted to its major metabolite, 
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cotinine, by way of the cytochrome P450 system (Benowitz, Kuyt, Jacob, Jones, & 
Osman, 1983).  The claim that nicotine is an addicting substance has been questioned 
in the past, but is more widely accepted today. In 1993, Hughes compared symptoms of 
tobacco use to the American Psychiatric Associations Diagnostic and Statistical Manual 
(DSM-III) criteria for drug dependence, and concluded that tobacco use met at least 5 out 
of 9 criteria including marked tolerance, characteristic withdrawal symptoms, and 
substance taken to relieve or avoid withdrawal symptoms.   Later, the DSM-IV was 
published which included a diagnosis of tobacco dependence (American Psychiatric 
Association, 1994) 
Nicotine has pharmacologic properties (Fisher, Haire-Joshu, Morgan, Rehberg, & 
Rost, 1990).  Nicotine exerts its action on the cardiovascular, respiratory, skeletal motor, 
and gastrointestinal systems through stimulation of peripheral cholinergic neurons via 
afferent chemoreceptors and ganglia of the autonomic nervous system (USDHHS, 1988).  
Inasmuch as both sympathetic and parasympathetic ganglia are stimulated by the 
presence of nicotine, the end result depends on the summation of the effects of the 
autonomic nervous system (USDHHS, 1988).  Generally, the resulting peripheral 
physiologic changes resemble sympathetic stimulation, but there are some effects of 
nicotine and smoking that lead to physiologic relaxation.  Common changes include 
increased heart rate and blood pressure, cutaneous vasoconstriction of distal extremities, 
relaxation of skeletal muscles, and increased gastric secretions with a decrease in motility 
(USDHHS, 1988).  In addition, several studies have reported that nicotine exposure can  
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lead to state-dependent learning effectsin other words, optimal cognitive/behavioral 
performance may come to depend upon the continued self-administration of tobacco 
(USDHHS, 1988).   
Nicotine is a psychoactive drug, which means that it is mood altering (USDHHS, 
1988).  Smokers report that with the self-administration of nicotine they feel euphoric, or 
have pleasant feelings.  Recent studies have shown a relationship between tobacco use 
and increasing levels of the neurotransmitter dopamine, and a decrease in monoamine 
oxidase B (MAO B), an enzyme involved in breaking down dopamine (Stephenson, 
1996).  The implication of this finding is that chronic inhibition of MAO-B works 
synergistically with the stimulation of dopamine by nicotine and adds to the pleasant 
moods and enhanced concentration abilities of those who smoke.  In addition, this also 
may be a pharmacological/physiological basis for nicotine as a gateway drug for other 
addictive substances such as alcohol (Stephenson, 1996).   
Tobacco use is influenced by the pharmacologic and psychologic factors 
associated with nicotine.  However, there are also social and environmental factors that 
strongly influence smoking behavior and continued use (Wewers and Ahijevych, 1996).  
While social and environmental factors influence the smoking behaviors of all smokers, 
the various social and environmental influences are specific to each smoker.  For 
example, persons with disproportionately higher rates of smoking include men (25.7%) 
versus women (21.5%); Native Americans and Alaska Natives (40.8%); those with a 
general education development diploma (44.4%) versus those with higher education 
(8.5%); and persons between the ages of 18-44 (27%) versus those over the age of 65 
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(10.6%) (CDC, 2001).  Other social/environmental variables that augment nicotine 
addiction include having family and friends who smoke and availability of smoking areas 
(McIntyre-Kingsolver, Lichtenstein, & Mermelstein, 1983; Ockene, Benfari, Nuttall, 
Hurwitz, & Ockene, 1982).  In addition, the desire to handle cigarettes may be an 
important reason for smoking.  Such stereotypical behaviors are characteristic of other 
forms of drug addiction and other compulsive behaviors not involving psychoactive drug 
self-administration (USDHHS, 1988). 
The controlled and compulsive use of nicotine is additional evidence of nicotine 
addiction.  Generally, naïve smokers begin smoking relatively few cigarettes per day, 
thus ingesting smaller doses of nicotine (USDHHS, 1988).  However, as dependence 
develops, the amount of nicotine increases and then plateaus resulting in years of stable 
nicotine use (USDHHS, 1988).  Most smokers maintain a certain amount of nicotine in 
their bodies despite type or size of cigarette smoked.  This is done by the smoker 
changing smoking topography, which is defined as the smokers puffing characteristics 
and the associated respiratory inhalation and exhalation movements (Ahijevych and  
Parsley, 1999). Researchers have found that if smokers are pretreated with nicotine (e.g. 
IV nicotine) they will decrease the amount of self-administered nicotine with subsequent 
cigarettes (USDHHS, 1988).  Conversely, if smokers are treated with a nicotine 
antagonist (e.g. mecamylamine), they will increase the amount of nicotine ingested with 
subsequent cigarettes (USDHHS, 1988).  Practically speaking, if a smoker begins to 
smoke light (low-dose nicotine) cigarettes after years of smoking regular brands, they 
may change smoking topography or block the filters on the cigarette to achieve a higher 
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level of nicotine ingestion.  This is called controlled use of nicotine.  Compulsive use of 
nicotine involves continuing to use the substance despite negative consequences.  This is 
clearly demonstrated by smokers who continue to smoke after laryngeal cancer or heart 
attack.  In fact, 50% of smokers resume smoking after a smoking related surgery (West 
and Evans, 1986).     
 Pharmacological, psychological, social, and environmental factors are all part of 
the nicotine addiction equation.  However, if the goal is to help people quit smoking, two 
other principles of addiction must be taken into consideration: tolerance and withdrawal.  
Tolerance involves needing greater amounts of nicotine to achieve the same 
pharmacological/physiological response.  Two proposed physiological reasons for 
tolerance are: increased metabolism over time, and a decrease or alteration in the number 
of nicotine receptors (USDHHS, 1988).  In general, the pharmacological and 
psychoactive nature of nicotine is influenced by individual metabolism of the drug 
(Benowitz, et al., 1990).  There are various reasons for inter and intra-individual 
variations in nicotine metabolism.  For example, eating increases nicotine metabolism by 
42%, which may contribute to the enjoyment of an after dinner cigarette.  There is also 
a genetic component to nicotine metabolism including number and type of nicotine 
receptors and enzyme activity.  In addition, Ahijevych, Gillespie, Demirci, and Jagadeesh 
(1996) found that cotinine values (the major metabolite of nicotine) were significantly 
higher in African American women than in Caucasian women despite fewer cigarettes  
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smoked by African American women, and no differences in smoking topography (except  
longer exhalation by the Caucasian women).  These authors advocated the need for  
urther research to investigate these differences. 
For persons who are trying to quit smoking, symptoms of withdrawal often cause 
relapse.  Withdrawal symptoms fall into three categories: autonomic (cardiovascular, 
respiratory, and gastrointestinal); somatomotor (reflexes, auditory/visual changes, 
nociception); and behavioral (irritability, restlessness, sleep/wake disorder, attention 
deficits, weight gain).  The most common withdrawal symptoms associated with nicotine 
are autonomic and behavioral in nature (USDHHS, 1988).  Many withdrawal symptoms 
will be relieved within three to five days, but often smokers suffer from one to two 
symptoms for a longer period of time, such as attention deficits and weight gain.  In 
assessing the risk for withdrawal symptoms, the number of cigarettes smoked per day is 
not considered a good predictor of withdrawal symptomatology (USDHHS, 1988).  
Levels of serum nicotine, or cotinine, are considered to have the best correlation with 
severity of withdrawal (Pomerleau, Fertig, and Shanhan, 1983).   
The addiction to, or dependence on, nicotine is a factor that must be dealt with if 
nurses are to effectively help claudicants quit smoking (Fagerstrom, Heatherton, and 
Kozlowski, 1990).  The Fagerstrom Test for Nicotine Dependence (FTND) was designed 
to indicate the strength of this dependence (Fagerstrom et al., 1990).  The FTND has been 
found to have adequate test-retest reliability, internal consistency of cronbachs alpha = 
.64, and validity as evidenced by a significant correlation with cotinine (+.39) 
(Pomerleau, Carton, Lutzke, Flessland, and Pomerleau, 1994).  Originally developed in 
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the late 1970s, the FTND has been refined and currently contains six categorical 
questions, yields a score between 0 and 10, and is used to measure degree of physical 
dependence and expected withdrawal symptoms (Heatherton, Kozlowski, Frecker, and 
Fagerstrom, 1991).  Clinically, the FTND is used to determine the need for nicotine 
replacement therapy as an adjunct to a smoking cessation intervention.   
Exercise Determinants 
 The US Public Health Service for the Year 2000 identified as a goal for the nation 
to understand the attitudes, environmental and social factors, and beliefs that are 
associated with exercise (Dishman and Sallis, 1994).  Since then, extensive research has 
been conducted to identify determinants of exercise adoption and maintenance.  
However, these research studies have been conducted with pre- and quasi-experimental 
designs, and as a result, the term determinant refers to an association or prediction, 
NOT a cause and effect relationship (Dishman and Buckworth, 1996). 
 Exercise determinants do not represent a theoretical model, but rather factors that 
are associated with level of physical activity or exercise behavior.  In several articles, 
exercise determinants have been classified according to characteristics of the person,  
characteristics of the environments, and aspects of the exercise itself (Buckworth, 2000; 
Dishman and Buckworth, 1996; Dishman and Sallis, 1994).   Many characteristics of the 
person, environment, and exercise have been studied to determine a correlation with 
exercise behavior.  Some of these characteristics have a documented lack of association,  
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or a weak or mixed association with exercise (Dishman and Buckworth, 1996).  Some of 
the characteristics that have consistently lacked an association include: knowledge of 
health and exercise, activity during childhood/youth, school sports, and cost.   
However, many characteristics have a consistent positive or negative association 
with exercise behavior.  Personal attributes that correlate with exercise behavior include 
demographic variables, psychological traits, and cognitive variables such as attitudes and 
beliefs (Dishman and Buckworth, 1996).  Specifically, characteristics that negatively 
correlate with exercise behavior include female gender (only at vigorous levels of 
activity), blue-collar occupation, lower income, and unmarried status (Buckworth, 2000).  
In addition, smoking has been found to negatively correlate with adherence to structured 
exercise programs (Franklin, 1988).  A trait measure of self-motivation, which seems to 
reflect effective goal setting, self-monitoring of progress, and self-reinforcement, has 
been found to consistently correlate positively with exercise (Knapp, 1988).  Finally, self-
efficacy (the belief in ones ability to perform the activity), self-schemata (seeing oneself 
as an exerciser), and intention are also strongly correlated with exercise behavior. 
Environmental factors that contribute to higher levels of physical activity include 
easily accessible facilities that are absent of real barriers to the exercise routine (Dishman 
and Buckworth, 1996).   Specifically, perceived accessibility to facilities has not been 
found to be a predictor of exercise behavior, but real accessibility (actual distance) seems 
to be related to both the adoption and maintenance of exercise behavior (Buckworth, 
2000).  In addition, social support from family and friends, particularly for women, 
appears to be a strong correlate of exercise behavior.   
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Physical activity characteristics that may influence exercise behavior include 
exercise mode (e.g. cycling versus running), intensity (e.g. low versus high), duration 
(e.g. ten minutes versus 60 minutes), and frequency (e.g. every day versus once a week) 
(Buckworth, 2000).  Frequency and duration of exercise have not been found to correlate 
specifically with exercise behavior (Dishman and Buckworth, 1996).  For example, 
people who are given an exercise prescription to exercise ten minutes, one day a week, 
are not any more likely to exercise than a person given an exercise prescription for 30 
minutes, five days a week.  However, mode of exercise does become a determinant when 
active leisure is compared to exercise programs of greater intensity (Dishman and 
Buckworth, 1996).  The implication here is that people may find it easier to adhere to a 
low intensity walking program than a high intensity dance aerobics program.  
Interestingly, although more intense forms of exercise decline with age, moderate 
intensity activities, such as walking, have been found to increase with age (Buckworth, 
2000). 
Although intervention studies are not conducted based on principles of exercise 
determinants alone, these factors must be taken into consideration when exercise 
adoption interventions are planned.  First, the clinician must consider the non-modifiable 
characteristics that may influence exercise behavior, such as gender, level of education, 
occupation, and age.  Second, modifiable characteristics should be assessed to identify 
what determinants may be able to be changed in the participants favor, such as self-
efficacy, social support, or self-schemata.  Finally, specific factors and their level of  
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influence will change as participants progress toward exercise adoption and maintenance,  
and clinicians must be willing to frequently reassess and modify the intervention 
(Buckworth, 2000). 
3.2  DEVELOPING A THEORY BASED INTERVENTION 
 Based on research, exercise training and smoking cessation are two of the most 
effective therapies for treating claudication (Christman et al., 2001).  Unfortunately, a 
paramount problem for clinicians is motivating targeted individuals with PAD to begin 
and adhere to an exercise regimen and/or quit smoking.  While supervised exercise yields 
significant improvements in pain free walking time, the prescriptions of these programs is 
limited by the number of medical centers offering them (Patterson et al., 1998; Degischer 
et al., 2002).  Home based exercise has been found to be a valid alternative to supervised 
exercise, providing a cost-effective intervention while still yielding significant 
improvements in pain free and maximal walking times (Patterson et al., 1998). 
Experts estimate that half the occurrences of PAD in the community might be 
attributable to smoking, and 90% of PAD patients in the hospital have a history of current  
or recent smoking (Fowkes, 1997).  The 5-year mortality rate for persons with PAD who 
continue to smoke is approximately 40-50%, similar to rates observed with many 
common cancers (Hirsch et al., 1997).  Nurse managed, home-based smoking cessation 
programs have been found to be highly cost-effective when cost and years of life saved 
were examined in patients with vascular disease (West, 1997).  While the typical 
smoking cessation rates among healthy adults offered group counseling is only 15%,  
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theory-based smoking cessation interventions can yield quit rates as high as 61% at 12  
months (Fiore, Bailey, Cohen, et al., 1996; Taylor, Houston-Miller, Killen, and DeBusk, 
1990).   
In light of the known benefits of exercise training and smoking cessation for 
treating intermittent claudication, and taking into consideration the practical limitations 
of supervised exercise programs along with the low smoking cessation rates associated 
with many smoking cessation interventions, an exercise adoption and smoking cessation 
intervention was developed for patients with PAD.  Specifically, we implemented a 
theory-based, nurse-implemented 12-week patient education program which was 
compared to the usual care provided of a one-time admonition to start exercising and quit 
smoking given by the vascular surgeon in the office.  The following will provide a 
detailed description of the intervention, how the TTM was used as a foundation for the 
intervention, and how the models of nicotine addiction and exercise determinants were 
used to promote behavior change.  In addition, some descriptive data will be presented 
which was collected during face to face or telephone contact with study participants, and 
recorded by the nurse implementing the program.    
The Transtheoretical Model of behavior change was used as the foundation for the 
intervention, with a 12-week educational intervention, and data collection points at 
baseline, 3-months, and 6-months post-enrollment.   Subjects were randomly assigned to 
either the intervention group, or the usual care control group in order to determine the 
effectiveness of the intervention.  In order to utilize the model to the fullest advantage, all 
of the core constructs were utilized.  At each data collection point, subjects were 
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classified into a stage of change for both exercise and smoking behaviors.  Valid 
classification of stage of change was enhanced by using a detailed and rather limited 
definition of exercise, and a specific definition of smoking cessation.  In addition, 
decisional balance for smoking cessation and exercise adoption, and exercise self-
efficacy were measured.  Finally, for those who smoked, expired carbon monoxide and 
saliva cotinine were measured in order to validate smoking status, and to help determine 
physical addiction to nicotine.   
The exercise prescription was individualized for each subject in the intervention 
group, and all exercise activity occurred during the participants own time.  A description 
of the important components of an exercise prescription to improve functional capacity in 
patients with lower extremity PAD can be found elsewhere (Christman et al., 2001; 
Chapter 2).  The educational intervention consisted of a weekly meeting for 12 weeks, 
and the content of the course was dictated by the theories from the TTM, nicotine 
addiction, and principles from the exercise determinant literature.  During the 12-weeks, 
the pros of behavior change were stressed, while the cons were discussed and 
misconceptions addressed.  For example, some people stated that it was hard to find an 
exercise activity they enjoy that was not affected by bad weather.  This problem was 
discussed in class, and each participant was able to state where and how they could 
exercise even if the weather was inclement.  For smokers, many believed that they were 
more relaxed and therefore more pleasant when smoking.  This problem was addressed 
by discussing principles of nicotine addiction.  First, the duration of nicotine withdrawal 
was identified (primarily 3-5 days), and the acknowledgement that one or two withdrawal 
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symptoms may last longer.  Second, strategies for dealing with these symptoms were 
identified, for example nicotine replacement or relaxation techniques.  In addition, the 
Clear Horizons smoking cessation manual was distributed.  The Clear Horizons manual 
is modeled after the format of the magazine Modern Maturity, is written at an 8th grade 
reading level, and introduces stage-specific quit-smoking strategies using examples of 
smokers in their 50's, 60's, and 70's (Morgan et al., 1996).   Non-smoking subjects also 
received a Clear Horizons manual, and were encouraged to be a part of the discussions 
and offer support and encouragement to their smoking counterparts, as positive peer 
support has been identified as a predictor of successful change.   
For each subject, stage of change for smoking cessation and exercise adoption 
was identified.  For those who participated in the intervention, specific strategies for 
helping them move to the next stage were utilized (Marcus, et al., 1992; Prochaska and 
Velicer, 1997).  For those in the earlier stages, cognitive and experiential processes of 
change were used, such as self-reevaluation and self-liberation.  For most smokers, they 
were already aware of the harmful effects of their behavior on themselves and others, so 
they were encouraged to think of themselves as non-smokers and as their thinking 
began to change, an actual commitment to change the behavior was scheduled (quit date).  
For those beginning an exercise program, consciousness-raising was the first step by 
helping them understand the relationship between PAD and sedentary lifestyle, followed 
by self-reevaluation and self-liberation.  These processes clearly coincide with the 
exercise determinants that are known to correlate with exercise adoption such as self-
schemata.  In addition, because social support is a strong predictor of successful change, 
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subjects were encouraged to tell their friends and family about the change, and elicit their 
support.  Finally, reinforcing the belief that subjects had the ability to successfully change 
was stressed, particularly regarding exercise behavior, in order to reinforce and improve 
their self-efficacy. 
As subjects moved into the action stage of stage, the processes used became more 
behavioral, and again utilized principles from the theory of nicotine addiction and from 
the exercise determinant literature (Fiore et al., 2000; Buckworth, 2000).  For smokers, 
counterconditioning and stimulus control became the most frequently used processes.  
For several smokers, a physical addiction to nicotine was identified, and they were 
encouraged to utilize nicotine replacement, and strategies to avoid high-risk situations 
were identified.  For example, one smoker with a Fagerstrom questionnaire score of 
seven (out of a high of 10) utilized nicotine replacement via the patch continuously, and 
added gum for breakthrough cravings (Fiore et al., 2000).  In addition, specific social and 
environmental factors contributing to nicotine addiction included such things as always 
smoking during bowling league, smoking only after work, smoking when at home 
because of stress from spouses illness, and many subjects acknowledged enjoyment of  
the hand-oral manipulation.  Again, counterconditioning strategies such as chewing 
gum, or playing with a rubber band or pencil were discussed.   Smokers also identified 
helping relationships, either in the form of a significant other, or in one case, divine help 
through prayer, as being very beneficial for them.  For those adopting exercise, 
counterconditioning, contingency management and helping relationships were most often 
used as behavioral processes.  One subject bought a treadmill, three joined senior health 
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clubs, and one person enrolled in the citywide activity challenge being promoted at the 
time.  In addition, others in the group and the facilitator of the class provided positive 
reinforcement for new behaviors, and many subjects stated that significant others in their 
lives were encouraging and positive about the change. 
Finally, at the end of the 12-week intervention, subjects were asked to sign a 
contract for maintaining the behavior change for a two-week period.  Contracting has the 
benefit of allowing the participant to develop a plan, provides a written statement of 
expectation, creates a form of public commitment, and provides a reward for goal 
attainment (Wewers, Ahijevych, and Sarna, 1998).  The contract included a clear 
description of the desired behavior, reinforcements of the behavior (or absence of the 
behavior), and criterion for time or frequency limitations (Martin and Dubbert, 1984).  
Subjects in the intervention group were contacted by telephone every two weeks for three 
months post-intervention for encouragement, to discuss the contract, and to discuss plans 
to continue or update the contract (Fiore et al., 1996; Lombard, Lombard, and Winett, 
1995).  Although these strategies are not a specific part of the theoretical model, they are 
consistent with principles of the TTM, and were used to promote maintenance of the 
behavior change. 
3.3  CONCLUSION 
 The transtheoretical model of behavior change, the theory of nicotine addiction, 
and principles from the exercise determinant literature were successfully integrated to 
develop a nurse-managed 12-week exercise adoption and smoking cessation intervention 
for patients with intermittent claudication.  The components from the TTM utilized to 
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form the foundation of the intervention included stages of change, processes of change, 
decisional balance, and self-efficacy (Prochaska et al., 1997).  The components from the 
theory of nicotine addiction that were integrated into the intervention included principles 
of physical, psychological, social, and environmental addiction, along with principles of 
withdrawal and the Fagerstrom Test for Nicotine Dependence (FTND) (USDHHS, 1988; 
Heatherton et al., 1991).  Factors from the exercise determinant literature that were 
discussed with intervention participants included exercise intensity, self-efficacy, social 
support, and actual distance from the exercise location (Buckworth, 2000).   
Exercise training is one of the most effective therapies for treating intermittent 
claudication, even when compared to pharmacological or surgical treatment (Stewart et 
al., 2002).  This theory-based intervention to promote adoption and maintenance of 
exercise behavior with claudicants utilized principles from the TTM which overlapped 
with one of the most widely studied exercise determinants, self-efficacy (McAuley and 
Blissmer, 2000).  For the intervention group, exercise self-efficacy was stressed during 
each class for the entire 12 weeks.  At the end of the program, baseline self-efficacy and 
three and six month exercise stage of change were correlated.  For all subjects (not 
separated by group), baseline self-efficacy correlated with 3-month exercise stage of 
change with a Kendalls tau-b coefficient of .357 (p < .05), but not with 6-month exercise 
stage of change (p = .173).  When divided by group, this correlation was not significant 
for the intervention group at 3- or 6-months, but actually became stronger for the usual 
care group at 3-months only (correlation coefficient .625, p < .01), while the 6-month 
correlation was not significant.  The implication from these results seems to be that for 
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those who begin with a high degree of confidence in their ability to begin and maintain an 
exercise routine, they will do so whether there is a formal intervention or not.  In contrast, 
even for patients who do not have confidence in their ability to begin and maintain an 
exercise regimen, this lack of confidence can be overcome with a structured, 
individualized intervention.   
Vascular clinicians have hypothesized that the discomfort of claudication and/or 
the fear of amputation might serve as motivators for effective tobacco cessation 
interventions in the PAD population if the link between smoking and this severe limb 
disease were reinforced by intensive counseling interventions (Hirsch et al., 1997).  
Using the TTM this link was made during the 12-week intervention, and using the theory 
of nicotine addiction, strategies for change were identified and implemented.  
Consciousness raising, one of the earliest cognitive processes of change, was used during 
the second weekly class.  An entire class time was committed to understanding the risks 
of smoking, and the relationship between smoking and PAD.   In addition, during this 
same class time, smokers in the class completed the FTND, and the concepts of nicotine 
addiction in all forms (physical, psychological etc) were discussed, along with symptoms 
of withdrawal and nicotine replacement (Fisher et al., 1990; Fiore et al., 2000).  Finally, 
both the TTM and the theory of nicotine addiction identify social support (or helping 
relationships) as being integral in successfully quitting smoking (USDHHS, 1988; 
Prochaska and Velicer, 1997).  Importance of social support was evidenced in this study 
when of the six smokers who failed to quit smoking, two had significant others who 
smoked, and three had a majority of friends who smoked.  In addition, this principle was 
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significant irrespective of group.  One of the usual care group members entered the study 
in the smoking stage of contemplation, but quickly jumped into preparation and then 
action when they started to date a non-smoker. 
In summary, the TTM, the theory of nicotine addiction, and exercise determinants 
were effective in developing a nurse-implemented exercise adoption and smoking 
cessation intervention for patients with PAD.  While study participants were not formally 
asked what they found helpful or not helpful about the program, at the end of the 6-month 
program, almost all intervention participants stated that they found the intervention to be 
generally helpful, and 85% of the intervention members (n=12) had moved into the action 
stage of exercise adoption.  While few smokers (n = 2) had moved into the action stage of 
smoking cessation at the end of the 6-month study (neither of them intervention group 
members), during subsequent telephone follow-up, six additional smokers stated that they 
had quit smoking, five of whom had been involved in the 12-week class. 
 Vascular nurses play an integral role in helping claudicants begin an exercise 
program and quit smoking.  Developing theory-based interventions may help claudicants 
be more successful in adopting and maintaining these healthy behaviors.  The 
transtheoretical model of behavior change, the theory of nicotine addiction, and exercise 
determinants should be considered when developing these interventions, as they are 
practical, and can be integrated to develop wholistic interventions that can be 
individualized to each patient and their situation.   In addition, the model of nicotine 
addiction and principles from the exercise determinant literature can be used to identify 
individual needs of participants within each stage of change.   
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  Cognitive/Experiential Processes 
Consciousness Raising: becoming aware of the dangers/effects of the behavior 
Dramatic Relief: feeling the emotional response associated with engaging in the behavior 
(e.g. fear of lung cancer) 
Self Reevaluation: starting to view oneself as not engaging in the unhealthy behavior (e.g. 
view oneself as someone who exercises) 
Environmental Reevaluation: becoming aware of the harmful effects the behavior has on 
others or the environment 
Self Liberation: committing to change the behavior 
Behavioral Processes 
Social Liberation: society's actions to promote the behavior change (e.g. no smoking 
zones, local activity challenges) 
Counterconditioning: taking action to replace harmful behavior with positive (e.g. 
nicotine replacement, joining a gym) 
Stimulus Control: avoiding high risk situations or developing coping strategies for high 
risk situations 
Contingency Management: positive reinforcement of the new behavior 
Helping Relationships: others who offer positive reinforcement of the new behavior 
Source: Prochaska et al., 1997 
 
Table 3.1 Processes of Behavior Change
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CHAPTER 4 
 
THE EFFECT OF A NURSE IMPLEMENTED, THEORY-BASED EXERCISE 
ADOPTION AND SMOKING CESSATION PROGRAM ON FUNCTIONAL 
STATUS, STAGE OF CHANGE, DECISIONAL BALANCE, AND SELF EFFICACY 
WITH CLAUDICANTS 
Lower extremity arterial occlusive disease represents a major cause of morbidity 
in the elderly, with a prevalence of up to 20% in those over the age of 70 years (Criqui, 
2001).  Up to 40% of patients with peripheral arterial disease (PAD) suffer from 
intermittent claudication, and the overall number is expected to increase by 
approximately 1 million every 2 years for the next 50 years (Kannel and McGee, 1985).  
Treatment options for claudication include lifestyle changes, drug therapy, vascular 
surgery, or any combination of the three (Golledge, Ferguson, Ellis, et al., 1999; 
Degischer, et al. 2002; Regensteiner et al., 2002).  
Lifestyle modifications for the treatment of claudication pain primarily include 
exercise training and smoking cessation (Christman, et al., 2001).  Exercise training alone 
has been found to increase time to onset of claudication pain by 179% and maximal 
walking time by 122% (Gardner and Poehlman, 1995).  Cigarette smoking is known to be 
a major contributor to PAD, including the progression of PAD from asymptomatic to 
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intermittent claudication, conversion of stable claudication to rest pain, increasing failure 
rate of limb bypass grafts and limb angioplasty, and increasing amputation rate (Fahey, 
1999).  Recent advances in drug therapy have been found to be effective in treating 
claudication.  Cilostazol (Pletal), an oral type III phosphodiesterase inhibitor has been 
found to increase pain-free walking distance by 59% and maximal walking distance by 
51% (Beebe et al., 1999).  In addition, the combination of a supervised walking program 
and Clopidogrel (Plavix), an oral antiplatelet, was found to improve claudication pain 
time (CPT) by 200.6%, and maximal walking time (MWT) by 131.4% (Degischer et al., 
2002).   Finally, for most patients who choose to undergo angioplasty or surgical 
revascularization to correct the arterial occlusion, post-operative technical success is 
obtained.  Improvement in MWT following angioplasty is equivalent to that found from 
exercise, and there can be a 75-100% improvement in MWT following surgical 
revascularization (Stewart, et al., 2002).  However, successful symptomatic outcomes are 
not always achieved, as evidenced by one report documenting symptomatic improvement 
one year post operatively in only 51% of those undergoing femoropopliteal angioplasty 
(Golledge, et al., 1999).   
Based on research, it is clear that exercise training and smoking cessation are two 
of the most effective therapies for treating claudication.  Unfortunately, a paramount 
problem for clinicians is motivating targeted individuals with PAD to begin and adhere to 
an exercise regimen and/or quit smoking.  Vascular nurses have a role in the 
collaborative care of claudicants, and should investigate ways to enhance exercise 
adoption and smoking cessation strategies.  While supervised exercise has been found to 
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be consistently more effective than home based exercise, the prescription of supervised  
exercise is still limited by the number of centers offering such programs (Patterson et 
al.,1997; Degischer et al., 2002).  In addition, while natural history studies with PAD 
patients have shown the benefits of a "non smoking" state, intervention studies to help 
claudicants quit smoking have yielded non-significant findings (Power et al., 1992; 
Fowler, Jamrozik, Norman, Allen, and Wilkinson, 2002).   
Since there is significant published research that supports the benefits of exercise 
training and smoking cessation for the treatment of intermittent claudication, we focused 
primarily on identifying factors that would promote adoption and maintenance of these 
behaviors with PAD patients.  Oberst (1989) has stated that atheoretical interventions are 
little more than trial and error regarding what does and does not work.  Comparatively, in 
studies where researchers have used strong theoretical frameworks to guide program 
development, the results have substantially more impact on practice and subsequent 
research than is the case for atheoretical studies.  As a result, three theoretical models 
were used to develop this nurse-implemented exercise adoption and smoking cessation 
program for persons with PAD.  These three models were: 1) the Transtheoretical Model 
of Behavior Change; 2) Nicotine Addiction; 3) Exercise Determinants. 
4.1  THEORETICAL BASE 
The foundational model used for developing this intervention was the 
Transtheoretical Model of Behavior Change (TTM) (Chapter 3).  The core constructs of 
the TTM are stages of change, processes of change, decisional balance, and self-efficacy 
(Prochaska and Velicer, 1997).  As people change a behavior, the five stages of change 
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through which they pass are precontemplation (no intention for change in the next 6 
months), contemplation (intend to change in the next 6 months), preparation (intend to 
change in next 30 days), action (change has occurred in last 6 months), and maintenance 
(changed more than 6 months ago).  Movement through these stages occurs in a cyclical 
manner and many individuals make several attempts at behavior change before reaching 
maintenance (Prochaska, et al, 1997).  The processes of change, which are the strategies 
used by people to move forward through the stages of change, involve 10 
cognitive/experiential and behavioral processes (Prochaska and DiClemente, 1983; 
Prochaska et al., 1997).   
Decisional balance reflects an individual's relative weighing of the pros (benefits) 
and cons (consequences) of behavior change.  The construct of decisional balance has 
been reported to be critical in predicting the success of smoking cessation efforts 
(Prochaska et al., 1997).  The construct of self-efficacy is described as an individual's 
beliefs regarding perceived capabilities in a particular domain.  Exercise self-efficacy is a 
widely studied construct, and has shown a consistent relationship with exercise stage, in 
addition to being one of the strongest predictors of present and future exercise behavior 
(McCauley and Blissmer, 2000; Buxton et al., 1996).   
While the TTM provided the structure for this intervention, principles of nicotine 
addiction and exercise determinants were used to develop personalized stage-specific 
interventions (Chapter 3).  Nicotine is the major addictive agent in tobacco, and provides 
euphoriant and sedating effects which serve as reinforcements for maintaining smoking 
behavior (USDHHS, 1988).  The four primary components of the nicotine addiction 
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model include pharmacological, psychological, social, and environmental factors (Fisher, 
et al., 1990).  However, when helping people quit smoking, the principles of nicotine 
tolerance and withdrawal must also be taken into consideration.  The Fagerstrom Test for 
Nicotine Dependence (FTND) was designed to indicate the strength of nicotine addiction, 
or nicotine dependence (Fagerstrom et al., 1990).  Originally developed in the late 
1970s, the FTND has been refined and currently contains six categorical questions, 
yields a score between 0 and 10, and is used to measure degree of physical dependence 
and expected withdrawal symptoms (Heatherton, et al., 1991).  Clinically, the FTND is 
used to determine the need for nicotine replacement therapy as an adjunct to a smoking 
cessation intervention.   
Exercise determinants are factors that are known to associate with or predict 
exercise behavior (Dishman and Buckworth, 1996).  These determinants can include 
characteristics of the person, the environment, or the physical activity (Buckworth, 2000).  
Some modifiable determinants of exercise behavior include self-motivation, intention, 
self-schemata (see yourself as an exerciser), and self-efficacy (confidence in the ability to 
engage in an activity).  Environmental influences include social support (stronger for 
women), and objectively measured access to facilities (physically close to the exercise 
location) (Buckworth, 2000).   
As a result, we designed a study to evaluate the effect of a theory-based, nurse-
implemented 12-week patient education program compared to the usual care provided of 
a one-time admonition to start exercising and quit smoking given by the vascular surgeon 
in the office.  The primary endpoints in persons with PAD were functional status, based  
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on treadmill walking time, smoking cessation rate, decisional balance scores for both 
exercise and smoking, exercise self-efficacy scores, and stage of change.  Three 
hypotheses were identified: 
H1   Intervention participants will have a greater increase in functional status, decisional 
balance for exercise adoption, and exercise self-efficacy compared to the usual care 
group from baseline to 3 and 6-months post enrollment. 
H2   Intervention participants will have a greater increase in decisional balance for 
smoking compared to the usual care group from baseline to 3 and 6 months post 
enrollment. 
H3   A greater percentage of intervention participants will progress forward through 
stages of change for exercise adoption and smoking cessation as compared to usual care 
group from baseline to 3 and 6 months post enrollment.   
4.2  METHODS 
Sample Selection and Recruitment 
Smoking and non-smoking men and women between the ages of 40 and 75 with 
arterial claudication symptoms, who did not exercise were recruited for the study.  A 
convenience sample was drawn from several large vascular surgery offices in a 
midwestern metropolitan area.  These patients were either deemed ineligible for surgery 
and referred for potential recruitment, or had already had surgery and were still 
claudicating.  Once a referral was made, the patient was either approached personally or 
sent a letter describing the study, with a phone call following the initial contact.  If 
interest in participation was expressed, patients were screened using a 5-item stages of  
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change questionnaire for exercise adoption and a 3-question algorithm for smoking 
cessation.  Once potential subjects were determined to be in the precontemplation, 
contemplation, or preparation stage for exercise and smoking (for those who smoked), 
additional health history questions were asked to determine the patients ability to 
participate in the program.  In addition, for patients with a known history of coronary 
artery disease, their cardiologist was contacted to obtain clearance for the patient to 
participate in the program.  One hundred and eight patients were referred by name to the 
study.  During the screening phone call, 57 people were excluded for lack of interest or 
because of inability to walk on a treadmill, 1 person was excluded because their 
cardiologist did not want them participating in an unsupervised exercise program, and 8 
people were excluded because they were already in the action or maintenance stages of 
exercise.   
Procedure 
Once patients were deemed potentially eligible via phone, they were scheduled 
for a screening visit, which was conducted either at a participating community hospitals 
cardiovascular laboratory, or in an exercise laboratory located in the College of Nursing 
on the campus of the Ohio State University.  As a result, this study was approved by both 
the Mt. Carmel Health Systems Institutional Review Board, and the Ohio State 
Universitys Institutional Review Board, and two informed consents were signed by each 
subject.  After signing informed consent, each patient underwent hemodynamic eligibility 
screening.  Intermittent claudication from arterial insufficiency was established by resting 
ankle-brachial index (ABI) of less than 0.9 and/or a decrease in ankle pressure of 15 
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mmHg or more after a standard exercise protocol (10 degree incline, 1.5 mph, 10 minutes 
of exercise).  Patients who did not meet these hemodynamic criteria or had ischemic rest 
pain or tissue loss were excluded.  Additional exclusion criteria included an inability to 
tolerate exercise as a result of comorbid illness such as arthritis or chronic obstructive 
pulmonary disease.    
Because a significant number of claudicants have associated coronary artery 
disease, all patients underwent additional cardiac screening before final enrollment in the 
program (Gajraj and Jamieson, 1994).  First, a 12-lead EKG was recorded at rest in the 
supine position, and another 12-lead EKG was recorded during the standard exercise 
protocol, which were read by a cardiologist.  EKG changes including ST segment 
depression, elevation, or dysrythmia during rest or exercise excluded patients from 
participating in the study.   
Forty-two people were personally screened, and four were deemed ineligible.  
One person failed cardiac screening and subsequently enrolled in a supervised cardiac 
rehabilitation program, one person had non arterial disease, one person did not claudicate 
during the 10 minute standardized test, and one person had no audible doppler signals in 
the affected extremity and was referred back to the vascular surgeon.  Thirty-eight people 
were successfully screened and were randomly assigned to either the 12-week education 
intervention, or the usual care group.  One person was unable to be contacted after the 
initial screening visit, and seven others were lost before the second data collection point 
for various reasons (Table 4.1 and Table 4.2).  There were thirty participants available for 
at least one follow-up data collection point, 16 in the usual care group, and 14 in the 
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intervention group, with an overall study demographic of 21 men and 9 women, and 17% 
African American (Table 4.3).  For these thirty participants, there were no differences 
between groups in the demographic or medical history characteristics at baseline, but 
there was a significant difference in their treadmill walking times at baseline, with the 
usual care group being able to walk significantly farther than the intervention group. 
Study Design 
Patients with arterial claudication were randomly assigned to either a 12-week 
education program consisting of a 1-hour class per week and a personalized home based 
exercise prescription, or to the usual care group, which consisted of an admonition by 
their vascular physician to begin exercising and quit smoking with no additional follow-
up.  The curricular content of the educational component and the study design were based 
on a 1997 study by Patterson and colleagues, where a supervised exercise program and a 
home based exercise program were compared, and an educational component provided 
for both groups (Patterson, et al., 1997).  The vascular nurses from the Division of 
Vascular Surgery at the Miriam Hospital in Providence, Rhode Island were contacted and 
a curricular outline was obtained.  The TTM, the model of nicotine addiction, and 
principles from the exercise determinant literature were used to modify the curriculum, 
which led to increased smoking cessation content, and an entire class time dedicated to 
strategies for maintaining behavior change.  Additional theory-based strategies were also 
used during the program to aid with behavior adoption and maintenance.  Outcome 
measures were assessed at baseline, 3-months and again at 6-months post-enrollment if 
the participant was available for follow-up.   
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Intervention  
The experimental condition consisted of a 12-week, one-hour per week group 
education session.  The average class size was four people, but one class had only two 
participants.  The rationale for having a class with so few participants was the desire to 
start the intervention as close to the time of enrollment as possible without a long wait for 
any one subject.  Participants received a folder of material developed by the nurse 
investigator teaching the course, and contained information related to weekly course 
content.  Each week, principles of exercise and smoking cessation were reviewed in 
addition to scheduled, weekly topics including (but not limited to): the natural history of 
claudication, controlling cholesterol, understanding nutrition labels, foot care for PAD 
patients, understanding and controlling hypertension, and understanding and controlling 
diabetes.   
An individualized exercise prescription was given to every intervention group 
member with initial frequency and duration based on physical ability, exercise history, 
and access to an exercise location.  However, each prescription was based on three 
primary components which included: 1) walking as the mode of exercise, 2) the goal of 
working toward an exercise frequency and duration of three times/week for at least 30 
minutes/session, and 3) incorporating near maximal claudication pain end point (near  
maximum walk time) during the exercise training program (Gardner and Poehlman, 
1995).  This prescription was based on a meta-analysis of 21 related research studies  
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which revealed that the predictors of change in claudication pain distances during  
exercise were independently related to these three exercise program components 
(Gardner and Poehlman, 1995). 
In addition, the Clear Horizons smoking cessation manual was distributed to all 
participants .  The Clear Horizons manual is modeled after the format of the magazine 
Modern Maturity, is written at an 8th grade reading level, and introduces stage-specific 
quit-smoking strategies based on the TTM using examples of smokers in their 50's, 60's, 
and 70's (Morgan et al., 1996).  Non-smoking subjects also received a Clear Horizons 
manual, and were encouraged to be a part of the discussions and offer support and 
encouragement to their smoking counterparts.  Positive peer support has been identified 
as a predictor of successful change (Heaney and Israel, 1996). No stage-specific literature 
was available for exercise promotion. 
Stage Specific Intervention.  Participants were identified by stage of change 
according to exercise and smoking behavior.  For those in the precontemplation and 
contemplation stages of change, cognitive/experiential processes of changes were 
primarily used.  Once a participant reached the preparation and action stages of change, 
behavioral processes were used more frequently (Chapter 3).   
Once a participant began to exercise, they were asked to keep an exercise diary 
that was reviewed each week with the nurse investigator.  Participants were identified as 
being in the action stage for exercise when they had begun to walk three or more times a 
week, for a total of at least 20 minutes per session, not including necessary rest times.  
They were encouraged to take rest breaks when they reached near maximal claudication 
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pain, and to resume exercise when the pain subsided.  In addition, we originally planned 
to confirm self-reported exercise using a pedometer provided to each participant.  The 
pedometer is a small device that is clipped to a belt or waistband, and calculates number 
of steps taken, miles walked, and calories burned, and has been found to be valid with the 
PAD population (Sieminski, Cowell, Montgomery, Pillai, and Garnder, 1997).  
Unfortunately, so many of the participants lost, sat on, or somehow lost track of their 
pedometers, that these data were very incomplete, and were not used.   
Participants were identified as being in the action stage of smoking cessation 
when they began to abstain from cigarettes.  The use of a self-selected nicotine 
replacement therapy, such as transdermal nicotine or nicotine inhaler, was encouraged as 
an adjunct to behavioral counseling (Fiore, et al., 2000).  Smoking status was confirmed 
using expired carbon monoxide levels, and saliva cotinine.   
Follow-up.  In order to promote maintenance of behavior change, at the end of the 
12-week class, participants were asked to sign a contract for maintaining the behavior 
change for a two-week period (Wewers, et al., 1998).  In addition, participants were 
contacted by telephone every two weeks post-intervention for encouragement and to 
discuss the contract and plans to continue or update the plan (Lombard, et al., 1995). 
Thus, each participant received a total of six follow-up phone calls.  
Usual Care 
This group received what is considered usual care.  Usual care consists of being 
told by the physician in the office that they should start exercising and quit smoking, but 
in this practice setting there was no additional follow-up.  These subjects were contacted 
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and seen by the coordinating nurse investigator for data collection on the outcome 
measures at baseline, three, and six months post-enrollment.  In addition, at the end of six 
months they were offered the opportunity to participate in the 12-week education 
intervention, but no additional quantitative data was collected during this time.  Six of 
sixteen usual care subjects decided to participate in the 12-week class after their 6-month 
wait time. 
Measures 
Exercise Measures.  A graded, progessive treadmill exercise test initiated at 1 
mph with a grade of 5%, increasing in speed and grade at 5-minute intervals through four 
stages to 2.5 mph at 10% grade was used to determine CPT and MWT in minutes and 
seconds.  Each of the four stages has a predetermined metabolic equivalent unit (MET) 
level, with the final stage equivalent to 6.4 METS.  The progressive treadmill test was 
repeated at 3-months (program completion) and 6-months.   
Constructs from the TTM.  Stage of Change for exercise and smoking cessation 
was determined by responses on the established respective questionnaires.  The exercise  
stage of change instrument has a Kappa index reliability over 2 weeks of .78, and 
concurrent validity was demonstrated by its significant association with the Seven Day 
Recall Physical Activity Questionnaire (Marcus, et al., 1992; Marcus and Simkin, 1994).  
The stage of change questionnaire for smoking cessation is a standard 3-item algorithm 
(Prochaska and Goldstein, 1991). 
Decisional balance was measured by subtracting the cons score from the pros 
score on a questionnaire specific to exercise and smoking.  For the 20-item smoking 
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questionnaire, principal components analysis had yielded two orthogonal components 
labeled positive beliefs (pros) and negative beliefs (cons) about smoking with 10 items 
for each component and internal consistency of .87 and .90, respectively (Velicer, 
DiClemente, Prochaska, and Brandenburg, 1985).  A balance score resulting in a more 
negative number indicates an individual having greater reasons to continue smoking, and 
as the score becomes positive, the cons of smoking outweigh the pros.  The 16-item 
exercise decisional balance questionnaire has an alpha coefficient for the 6-item cons 
subscale of .79, and for the 10-item pros subscale of .95 (Marcus, Rokowski, and Rossi, 
1992). The higher the balance score, the greater the individual's reasons for beginning or 
adhering to an exercise program.  For both exercise and smoking, decisional balance was 
measured on a Likert scale from zero to five for each item.  Decisional balance for 
exercise was measured for all subjects at each time point, and decisional balance for 
smoking was measured at each time point for smokers only.   
Exercise self-efficacy was measured using a 13-item questionnaire specific for 
exercise, with responses on each item ranging from zero to 100, with an internal  
consistency of .88 which correlated significantly with exercise behavior (r = .52, p < .05) 
(McAuley, 1992).  This questionnaire was designed to assess subjects perceived 
confidence in their ability to exercise three times per week in the face of barriers to 
participation (McAuley, 1992).  The highest score possible on this questionnaire is 1300, 
with the high score indicating complete confidence.  Smoking cessation self-efficacy was  
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not measured because overall self-efficacy for smoking cessation peaks at 18 months, 
with the temptation component of self-efficacy for smoking leveling out at approximately 
36 months after quitting (Prochaska and DiClemente, 1984). 
Smoking cessation rate.  The number of participants who smoke was 
biochemically confirmed at baseline, and for those who smoked at 3 and 6-months.  A 
non-smoking status was defined as a salivary cotinine level <14ng/ml (Jarvis, Tunstall-
Pedoe, Feyerabend, Vesey, and Saloojee, 1987). Cotinine, the primary metabolite of 
nicotine, is considered the most valid marker of tobacco smoke exposure, and detects 
light and intermittent smoking (Benowitz, 1983). Since cotinine levels are not appropriate 
for those on nicotine replacement therapy, expiratory carbon monoxide (CO) levels also 
were measured at baseline, 3 and 6 months.  CO in expired air <8 parts per million is 
identified as nonsmoking status (Jarvis, et al., 1987).  The sensitivity and specificity of 
CO for confirming smoking status has been reported at 95.8% and 100% respectively 
(Stookey, Katz, Olson, Drook, and Cohen, 1987). 
Statistical Methods 
Hypothesis one involved comparing the change over time in functional status 
(CPT and MWT), decisional balance for exercise adoption, and exercise self-efficacy by  
group from baseline to six months.  The change over time in CPT, MWT, exercise 
decisional balance, and exercise self-efficacy was determined using slope analysis (Suter, 
Wilson, and Naqvi, 1991).  This strategy involves regressing each participants dependent 
variable (CPT and MWT) on time (baseline, 3-months, and 6 months).  Once the slope 
was computed, a number was generated as the slope value (beta) for each subject.  An 
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independent samples t-test was then used to determine differences between experimental 
and control groups based on the slope of each outcome variable.  To determine within 
group differences, a one-group t-test was used, by comparing the beta value of the 
intervention group to a zero value to determine change from baseline to 6 months.  
Finally, post hoc analyses were conducted using t-tests to determine differences in each 
variable at each time point between groups, and paired t-tests to determine differences 
between two time points within group. 
Hypothesis two involved assessing the change in smoking decisional balance over 
time by group from baseline to six months.  The change over time in smoking decisional 
balance by group was initially assessed using slope analysis as stated above.  In addition, 
post hoc t-tests and paired t-tests were used to determine if there were differences at 
individual time points both between and within groups, respectively.  Significance was 
set at p < .05. 
Hypothesis three involved comparing the number of smokers who quit smoking 
over time by group, and comparing the number of participants who progressed forward 
through the stages of change for exercise adoption by group from baseline to three and 
six months post treatment.  The movement across stages by group was assessed using a 
chi-square for two independent samples.  This test was used to examine between group 
differences at baseline, 3 and 6 months.  In addition, at each of these three data points a 
Wilcoxon Signed Ranks test was used to examine within group differences related to 
movement between stages.  These nonparametric statistics were appropriate because 
stage of change is ordinal level data involving counts or number of people per cell (Pett, 
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1997).  In addition, in order to identify factors that related to adoption and maintenance 
of successful behavior change (stage of change), non-parametric correlations were 
conducted using the Kendalls tau b as the correlation coefficient.  For these correlations, 
a one-tailed test was selected because the relationship between variables had been 
previously determined by the theoretical base of the study.  All statistical analyses were 
conducted with the aid of SPSS for Windows 9.0. 
During the 12-week intervention, during data collection appointments, and during 
follow-up telephone conversations notes were taken on comments made by participants.  
These statements were reviewed, and when similar comments were made by several 
participants, these were taken note of, and are reported here.  In addition, for intervention 
and usual care participants who had to withdraw from the study early, follow-up phone 
calls were made, and self-reported exercise routines and smoking cessation rates are also 
reported here. 
Based on previous research, the change in functional status was expected to yield 
a large effect size (Patterson et al., 1997).  Thus, a power analysis for a repeated measures 
design using a large effect size, an alpha of .05, and a power of .80 was conducted, and 
determined the need for a sample size of 28, with 14 in each group (Stevens, 1996).  To 
account for attrition, thirty-eight subjects were recruited, and the final sample yielded 14 
in the intervention group and 14 in the usual care group available for analysis.   
4.3  RESULTS 
 Thirty of the initial 38 participants were available for follow-up data collection.  
The baseline demographic characteristics of these 30 participants are found in Table 4.3.  
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There were no differences between groups except in walking times, with the usual care 
group being able to walk pain free almost two minutes longer than the intervention group, 
and maximally walk about four minutes longer than the intervention group.  About 70% 
of both groups were men, almost half were current smokers, the vast majority had 
hypertension, and close to half had some form of diabetes.   Many had never exercised 
before, very few had undergone a vascular surgery despite ankle brachial indices that 
would indicate rather severe claudication, and close to half were taking Cilostazol (Pletal) 
to help manage their disease.   
Of the 38 subjects initially screened and enrolled in the study, 21 were originally 
assigned to the intervention group, with 14 participants completing the 12-week program 
and available for 3-month follow-up (Table 4.2).  After enrollment, it was determined 
that one intervention group participant was not able to fully comprehend the abstract 
nature of the decisional balance and self-efficacy questionnaires, and they were not 
completed by this participant.  There was additional attrition after the 3-month time point 
(Table 4.1), and at six months there were 10 intervention subjects available for follow-up 
(Table 4.2).  The 6-month discrepancy between the treadmill walking time number (n = 
9) and the questionnaire number (n = 10) was a result of one intervention subject having 
such high blood pressure at the 6-month appointment that they were sent to the 
emergency room and did not complete the treadmill test. In contrast, seventeen 
participants were originally assigned to the usual care group, with fourteen available for 
3-month follow-up, and twelve available at 6-month follow-up (Table 4.1).  Two of the 
usual care participants were unable to come for 3-month data collection, but were 
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available at 6-months.  Reasons for attrition included medical problems (4); cardiac 
disorders (3) although no cardiac problems were reported during exercise, but rather 
found during routine cardiology appointments; surgery (3) with two usual care group 
members requiring peripheral revascularization, and one intervention group member 
needing a carotid endarterectomy; and inability to contact or refusal to further participate 
(7) (Table 1).  It may be notable that most of those lost to follow-up were intervention 
group members.  Perhaps the commitment was more than they had anticipated, or 
perhaps their health was a bit more unstable, with a loss of 6 intervention group members 
to health problems, versus 4 for the usual care group. 
Exercise variables 
 A significant between group difference was found for exercise stage of change 
over time (Table 4.4).  There were no differences between groups at baseline, with 50% 
of each group in preparation, about 20% of each group in contemplation, and about 30% 
of each group in precontemplation.  However, at the 3-month time point, 85.7% of the 
intervention group (n = 12) had moved into action, with only 21.4% of the usual care 
group (n = 3) having moved into action.  At the 6-month time point, there was no 
significant difference between the groups, but it is notable that 40% of the intervention 
group (n = 4) had progressed into the maintenance stage of exercise, while only 17% of 
the usual care group (n = 2) had done the same.   
 The functional status measures (CPT, MWT), along with exercise decisional 
balance and self-efficacy were assessed for between group differences according to 
change over time with slope analysis (Table 4.5).  There were no significant between 
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group differences on any of these measures.  While there was a greater change in walking 
time for the intervention group versus the control group (e.g. slope of 186.5 intervention 
versus 70 usual care), because of the wide variability in scores for both groups (as 
evidenced by standard deviations greater than 200), this difference was not significant.  
While a positive slope value indicates an increased score over time, conversely a negative 
slope value indicates that the scores decreased over time.  For both the intervention and 
usual groups, exercise decisional balance scores decreased slightly.  As expected, 
exercise self-efficacy scores increased for the intervention group as evidenced by a 
positive slope value (94), but actually decreased for the usual care group (-105) (Table 
4.5).   
Table 4.6 illustrates significant within group differences for exercise variables.  
The intervention group did have significant increases from baseline (p < .05) in CPT and 
MWT (Figures 4.1 & 4.2; Table 4.6).  These differences were found at 3-months and 6-
months with CPT (70% and 90% respectively), and only at 3-months for MWT (35%), 
even though there was a 30% increase (p = .07) from baseline to 6-months in MWT for 
the intervention group.  There were no within group changes for exercise decisional 
balance or self-efficacy for the intervention group.  In comparison, there were no within 
group differences in the usual care group for CPT, MWT, or exercise decisional balance, 
except for a significant drop (p < .05) in self-efficacy scores (Table 4.6).  While there was 
an increase in CPT and MWT for the usual care group as a result of two control group  
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participants who began to exercise routinely, most of the control group participants 
maintained stable walking times or even decreased walking times in some cases, and 
therefore the overall change was not significant.   
Based on the theoretical models used to develop this intervention, several 
variables were assessed for correlation with exercise stage of change at different time 
points.  The only measure that significantly correlated with exercise stage of change was 
the baseline self-efficacy score.  In fact, for all subjects (not separated by group), baseline 
self-efficacy correlated with 3-month exercise stage of change with a Kendalls tau-b 
coefficient of .357 (p < .05), but not with 6-month exercise stage of change (p = .173).  
When divided by group, this correlation was not significant for the intervention group at 
3- or 6-months, but actually became stronger for the usual care group at 3-months only 
(correlation coefficient .625, p < .01), while the 6-month correlation was not significant. 
Smoking variables 
 There were 15 self-reported smokers who enrolled in the study and were available 
for at least one follow-up visit.  Initially, only 13 participants (43%) self-reported 
smoking.  However, following high baseline CO levels, two additional participants 
admitted to smoking.  Biochemical confirmation of salivary cotinine levels, which detect 
smoking history up to seven days, took longer to analyze.  Based on cotinine analysis, 
there were 15 smokers, five in the intervention group, and 10 in the usual care group.  
One self-reported smoker had a zero level of salivary cotinine, (but an elevated CO), one 
self-reported smoker had a zero level of salivary cotinine (and a low CO) but stated she 
did not inhale when she smoked, and two self-reported non-smokers had elevated 
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cotinine concentrations (but low CO levels).  Cotinine is widely accepted as the most 
valid marker of tobacco smoke exposure (Benowitz, 1983), and has a sensitivity and 
specificity of 99% and 91.5% respectively (Murray, Connett, Lauger, and Voelker, 
1993).  It is unclear why two usual care group members stated they were non smokers 
when biochemical analysis revealed otherwise.  Both stated they had quit smoking more 
than 10 years previously, both had CO levels < 8ppm, and neither expressed any concern 
about collection of a saliva sample.  Perhaps they were consuming smokeless or pipe 
tobacco and did not consider this cigarette smoking, or were using a form of nicotine 
replacement therapy.  The reason one self-reported smoker had a zero level of cotinine 
but a high CO level is unclear.  Because of the delay in receiving cotinine assay results 
from the laboratory, follow-up smoking data beyond baseline were not obtained from the 
two usual care smokers who self-identified as former smokers.  In order to report 
conservative smoking cessation rates, these two usual care members were classified as 
smokers according to stage of change, but are not included in other smoking analysis.  
The two self-reported smokers whose cotinine values were low, are considered smokers 
and are included in all smoking data analysis.  Therefore, smoking data for the two self-
reported smokers who were biochemically identified as smokers is included only on 
Table 4.8 where they are classified as smokers in the earlier stages of change at all time 
points.  In addition, unless specified otherwise, the text will refer only to the smoking 
data for the 15 self-reported smokers in the study, since additional smoking data was not 
collected for the two additional usual care group tobacco users.  
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Six smokers were randomly assigned to the intervention group, and nine smokers 
were assigned to the usual care group.  There were no differences between groups on any 
of the pertinent smoking demographic variables including age, number of years smoked, 
and age of smoking initation (Table 4.7).  In addition, variables that tend to identify level 
of nicotine addiction such as time to first cigarette of the day, finding it difficult not to 
smoke in forbidden places, smoking more frequently in the morning than later in the day, 
smoking when so ill as to stay in bed, and mean Fagerstrom questionnaire score were not 
different between groups (Table 4.7).    
Smoking variables that were measured at baseline, 3 and 6-months were 
decisional balance and smoking stage of change.  There were no significant changes in 
either of these variables when comparing groups.  Table 4.5 shows the lack of between 
group differences on smoking decisional balance score as evidenced by similar slope 
values indicating that both groups experienced increases in overall scores.  Table 4.8 
shows the distribution of participants according to smoking stage of change at every time 
point by group.  Table 4.8 also indicates overall smoking rate, as the action stage is 
defined as complete smoking cessation, with one participant in each group having 
reached the action stage at 3-months, and one participant in the usual care group reaching 
action at 6-months.  The usual care member who was in action at 6-months was not the 
same usual care member who was in action at 3-months, as the latter had dropped out of 
the program due to lack of time.  In addition, when groups where compared individually, 
there were no within-group differences on any of the smoking variables. 
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As a result of the lack of significant findings by group, all the smokers were 
collapsed into one group, and analyzed for overall smoking trends and correlations.   
Table 4.9 shows mean decisional balance scores for all smokers which did not change 
over time.  However, when stage of change data was analyzed for significant differences 
by time point, there was a significant change at 3-months (p < .05), with two participants 
overall moving into action, compared to baseline, but this significant change was not 
maintained at 6-months.  This move into the action stage of smoking cessation is 
reflected in the significant change in CO values from 23 ppm at baseline, to 16 ppm at 3-
months, and remaining lower at 16 ppm at 6-months (Table 4.9).  This change is not 
reflected in the cotinine analysis because at 3-months four people were using nicotine 
replacement, and at 6-months, one person was on nicotine replacement.  
Because there was no evidence that the intervention resulted in significant 
smoking cessation rates, other factors were analyzed for predictors of smoking stage of 
change movement.  Two variables were found to significantly correlate with 3-month 
stage of change for the group of all smokers (Table 4.10).  The first variable, baseline 
smoking decisional balance, confirms the premise of the TTM that the cons of smoking 
must outweigh the pros in order for successful change to occur.  The positive correlation 
indicates that higher baseline decisional balance scores (greater cons of smoking) 
correlated with the higher smoking stages of change (preparation and action).  The 
second variable, difficulty not smoking in forbidden places, reflects the effect of nicotine 
addiction.  The question was asked so that a yes answer was coded 1, and a no 
answer was coded 2, thus at baseline, smokers who found it more difficult to refrain 
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from smoking in forbidden places were more likely to still be in the early 
(precontemplation and contemplation) stages of change at 3-months.  Neither of these 
correlations were significant at 6-months. 
 In summary, two smokers out of 17 (12%) completely quit smoking during their 
time in the study, both of them in the usual care group.  The one intervention group 
member who quit smoking at 3-months was still smoking two cigarettes a day at 6-
months per self-report.  However, almost all smokers reported smoking fewer cigarettes a 
day by the end of their study time, which is supported by the significant decrease in CO 
levels.  Additional qualitative analysis was conducted based on personal interview and 
telephone follow-up with many smokers.   Four usual care members who smoked chose 
to participate in the 12-week educational course after their 6-month wait time was  
completed.  Three out of these four quit smoking during the 12-week class, and remained 
quit at the time of the final telephone follow-up.  However, their data is not included in 
the statistical analysis because this study did not have a cross-over design.   The three 
subjects who dropped out to have vascular surgery (2 usual care and 1 intervention) had 
also quit smoking after surgery per self-report.  Finally, one intervention subject who cut 
back on number of cigarettes smoked/day during the program, reported during a 
telephone follow-up a complete cessation of smoking after a cardiac procedure, and 
reported maintenance of cessation at a 1-month follow-up phone call.    
Including the two usual care subjects who quit smoking during their time in the 
study, and the seven who quit smoking after they were out of the study, a total of nine 
smokers (53%) had quit smoking as of the last telephone contact.  In addition, those who 
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were still smoking reported a decrease in the number of cigarettes smoked per day from 
baseline (m = 15) to the final follow-up phone call (m = 9).  From statements made by 
smokers during one on one conversation, three themes were identified as motivators for 
quitting smoking (Table 4.11).  The first theme, time to prepare, was identified after 3 
usual care group smokers quit smoking during the 12-week class they had waited to take.  
All three of these smokers had stated during their 6-month wait time that they were 
waiting for the class, and they were planning to quit.  One of these smokers started to 
smoke again after the need arose to care for ailing parents, but then quit again about a 
month later.  The second theme, significant life event, was identified when 4 smokers 
quit smoking after a major invasive procedure (3 vascular and 1 cardiac), and 1 smoker 
quit after a sister was diagnosed with cancer.  These major life events seemed to give 
these smokers the motivation to quit smoking after years of trying to do so.  The last 
theme, effect of significant other, was identified exclusively for one smoker, but seemed 
to play a part in the quit attempts of others.  One usual care smoker quit smoking when 
they started dating a non smoker.  Up until that point, this person was in the 
contemplation stage of change, but jumped into action for the sake of this new 
relationship.  In this case, the effect of a significant other had a positive effect, but this 
theme was echoed with other smokers, particularly those who struggled to quit.  Out of 
the remaining 6 subjects who failed to quit smoking, 2 had significant others who 
smoked, and 3 had a majority of friends who smoked.   
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4.4  DISCUSSION 
 Home-based walking programs have been found to be effective for improving 
claudication pain time and maximal walking time for patients with lower extremity PAD 
(Patterson et al., 1997; Degischer et al., 2002; Binnie, Perkins, and Hands, 1999).  In the 
current study, intervention group participants had a significant improvement in CPT 
similar to other home-based programs (Patterson et al., 1998; Degischer et al., 2002).  In 
addition, while the overall improvement in MWT for the intervention group was less than 
some researchers have reported (35% versus 70%) (Patterson et al., 1998), this  
improvement was better than others have reported (35% versus 5.4%) (Degischer et al., 
2002).   
It was hypothesized that there would be a significantly greater increase in CPT 
and MWT for the intervention group than the usual care group, and the lack of significant 
between group difference was unexpected.  Knowing that exercise self-efficacy is a 
strong predictor of current and future exercise behavior (Dishman and Buckworth 1996), 
the plan was to work with the intervention group to improve confidence in their ability to 
exercise, hence increasing self-efficacy and increasing their chance of successfully 
adopting a routine exercise program.  However, for all study participants, regardless of 
group, baseline self-efficacy was found to significantly correlate with exercise stage of 
change. In fact, this correlation was even stronger for usual care group members, but was 
not significant for intervention group members.  As a result, individual baseline self-
efficacy scores for usual care members were reviewed.  Out of the four usual care 
members with the highest baseline self-efficacy scores (m = 1100), at 3-months three 
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were in the action stage of change for exercise and one was in the preparation stage.  At 
6-months two had moved on to the maintenance stage of change, one had regressed back 
to preparation, and one had moved into action.   In contrast, almost all intervention group 
members moved into the action stage at 3-months despite baseline exercise self-efficacy 
scores.  In fact, at 3-months the two intervention members with the lowest baseline self-
efficacy scores (m = 390) both moved into the action stage of change, while at 6-months 
one moved on to maintenance.  The implication from these results is that those who 
initially have a high degree of confidence in their ability to begin and maintain an 
exercise routine, will do so whether there is a formal intervention or not.  In contrast, 
even for patients who do not have confidence in their ability to begin and maintain an 
exercise regimen, this lack of confidence can be overcome with a structured, 
individualized intervention.   
At the beginning of the study, it was hypothesized that there would be a 
significant increase in the pros of exercise and a significant decrease in the cons of  
exercise, resulting in a change in exercise decisional balance score for the intervention 
group, but not the usual care group.  This difference was not realized, probably because 
both groups started out with a basic belief in the pros of exercise, resulting in high 
baseline decisional balance scores that were maintained over time.  The possible range of 
decisional balance scores has a low of -20 up to a high of 44, and for both groups the 
average baseline score was in the low 20s.  This may have been a result of the 
recommendation to begin exercising given by a vascular physician to all study 
participants at the beginning of the program. 
90
 
At the 3-month data collection point, 86% of the intervention group had 
progressed to the action stage of exercise adoption compared to 21% of the usual care 
group.  At 6-months, 40% of the intervention group (n = 4) had progressed on to the 
maintenance stage.  Many intervention subjects started to exercise upon enrollment.  
Random assignment to group occurred at the end of the screening visit, and subjects 
knew at that time if they would be part of the class immediately, or be asked to wait 6-
months.  Several intervention participants asked what type of exercise they should begin, 
and began to exercise at that time point, before the class actually started.  This allowed 
four intervention group members to reach maintenance by the 6-month data point.  In 
fact, the number of participants in the intervention group who progressed on to 
maintenance may have been greater than four.  Two intervention group members who 
dropped out of the program for cardiac and surgical reasons reported that they were still 
exercising regularly despite having to take some time off for medical treatments, however  
this is not reflected in Table 4.4.  None of the usual care subjects who had to drop out of 
the program were exercising per follow-up phone call. 
While 70% of the intervention group reached action or maintenance for exercise 
adoption by the 6-month data point, 58% of the usual care group also reached action or 
maintenance by the same time point, which resulted in a lack of significant difference 
between the groups at 6-months (Table 4.4).  This may have been a result of the usual 
care group participants being told that at the end of the 6-month usual care period, they 
would have the option of taking the same class offered to intervention participants.  Six 
usual care subjects chose to participate in the class, one of whom was in the maintenance 
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stage of exercise adoption, three were in the action stage, one was in preparation, and one 
was in the precontemplation stage of exercise adoption, but stated they wanted to take the 
class to quit smoking (which they did).     
The smoking cessation rates for the current study were a dismal 0% for the 
intervention group and 18% for the usual care group.  It is not surprising that other 
intervention studies aimed at smoking cessation with PAD patients have found similar 
non-significant results (Fowler, Jamrozik, Norman, Allen, and Wilkinson, 2002; Power et 
al., 1992).  In 1997, Hirsch and colleagues from the Vascular Medicine Program in 
Minneapolis, MN hypothesized that the discomfort of claudication and/or the fear of 
amputation might serve as motivators for effective tobacco cessation interventions in the 
PAD population if the link between smoking and this severe limb disease were reinforced 
by intensive counseling interventions (Hirsch et al., 1997).  While the current study does 
not give statistically significant evidence to support this hypothesis, the anecdotal 
evidence does suggest support.  Five out of the nine people who self-reported quitting 
smoking completed the 12-week intervention program.  Two of the five did not quit until 
a month after the end of the intervention when they underwent a significant life event, 
and the other three participated in the 12-week intervention after completing the 6-
months control group period.  However, with all five, the link between smoking and their 
disease had been made, and strategies for successfully quitting were provided.  The 
implication of these results is that it may be a more cost-effective use of resources to 
combine smoking cessation interventions with major health related events.  This could be  
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done by offering individualized smoking cessation counseling to all claudicants 
undergoing vascular procedures, with initial counseling beginning in the hospital and 
follow-up continuing after discharge.   
Smoking decisional balance scores did not change significantly over time by 
group, or for the entire sample of smokers.  There is however strong support in the 
literature for a relationship between smoking decisional balance and stage of change 
(Prochaska et al., 1997), which was identified in the current study.  In addition, many 
factors contribute to nicotine addiction including physical, emotional, social, and 
environmental factors (Fisher et al., 1990).  All but one smoker in the intervention group 
was encouraged to use nicotine replacement as an adjunct to the smoking cessation 
counseling received in class, but only three intervention group smokers chose to use 
nicotine replacement.  Of those three, one was in the action stage of smoking cessation at 
3-months, but was back to smoking about two cigarettes a day at 6-months.  The other 
two smokers had cut back in number of cigarettes used per day, but had not quit smoking 
at 3 or 6 months.  In addition, one of the usual care members who quit smoking used 
transdermal nicotine replacement to aid in smoking cessation.   
The other variable that correlated with smoking stage of change was the smokers 
ability to refrain from smoking in places where it is forbidden, such as airplanes and 
movie theatres.  This question is significant in that it reflects degree of addiction, but 
does not specify type of addiction.  Smokers who find it difficult to refrain from smoking 
in places where it is forbidden may have a physical need to smoke, or perhaps a social 
need to smoke, as there is evidence that hand-oral manipulation contributes to degree of 
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addiction (USDHHS, 1988).  In addition, the question of smoking in forbidden places is 
just one of the six questions on the Fagerstrom Test of Nicotine Dependence (FTND).  
While the total FTND score did not correlate with smoking stage of change at three or six 
months, this single question did.  The reason for the lack of correlation between the 
FTND score and smoking stage of change is not clear.  However, researchers have found 
that the question of smoking in forbidden places can differentiate between groups 
according to CO level (Heatherton et al., 1991).  Upon further investigation of this group 
of smokers, there was a significant correlation between those who found it difficult to not 
smoke in places where it is forbidden and 3-month CO level (Kendalls tau b coefficient 
= -.541, p < .05), but not at six months (Kendalls tau b coefficient = -.519, p = .122).  
The negative correlation indicates a relationship between those who find it difficult to 
refrain from smoking in forbidden places (yes = 1 and no = 2), and a higher CO level.  
The implication of this finding may be that for this group, this single question captured 
the degree of nicotine addiction better than the total FTND score.   
The positive correlations between decisional balance and smoking stage of 
change, and between smoking in places where it is forbidden and smoking stage of 
change emphasize the importance of assessing a smokers view of the cons versus pros of 
smoking, and their level of addiction before beginning a smoking cessation intervention.  
This allows the clinician to address the unique needs of the smoker before an 
individualized intervention is begun. In addition, because of the influence that significant  
others seemed to have on successful behavior change, it may be prudent, if possible, to 
have significant others take part in smoking cessation interventions. 
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There are several limitations of this study.  First, the sample size was adequate to 
detect the large improvements in functional status and the movement through the exercise 
stage of change, yet attrition resulted in a small sample size at 6-months.  Although these 
results support the hypothesis that a theory-based intervention is beneficial for helping 
people adopt exercise behavior, the total attrition of 17 subjects over the course of 6-
months limits the conclusions about this intervention significantly influencing 
maintenance of exercise behavior.  Second, there was considerable variability within the 
groups.  This is evidenced in Table 4.5 by the large standard deviations of the slopes for 
CPT, MWT, and exercise self-efficacy.  The implication of this is that wide variability in 
the outcome measures may have resulted in lack of or decreased statistical significance 
that could have been accounted for by a larger sample size.   Third, although the only 
baseline characteristics that were significantly different between groups were CPT and 
MWT, this may have been a reflection of an overall difference in physical health.  Even 
though there were not significant differences in health history between groups, there were 
more intervention subjects with hypertension and diabetes, and fewer taking Pletal.  
Other researchers have matched groups at baseline according to MWT and CPT 
(Patterson et al., 1997), which may be a consideration in the future.  Finally, there may 
have been limitations of the TTM that were not fully taken into consideration.  Stage-
matched interventions generally are developed based on homogeneity of subjects within 
each stage.  In addition to the development of a high intensity intervention, an effort was 
made to overcome this problem by utilizing principles of nicotine addiction and exercise 
determinants to administer individualized exercise prescriptions and smoking cessation 
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counseling.  However, particularly for smokers, those in precontemplation and 
contemplation may not have been challenged enough to set a quit date, and take action 
during the course of the intervention (Spencer et al., 2002) 
Despite the limitations, the results of this study are significant.  These results 
support the premise that a nurse-managed, theory-based exercise adoption intervention is 
effective in helping claudicants adopt a routine exercise program.  In addition, when  
combined with a critical life event, a nurse-implemented, theory-based smoking cessation 
intervention may contribute to claudicants successful smoking cessation.  Considerations 
for future research should include implementing such a program with a larger group of 
PAD patients, and combining the smoking cessation portion of the program with 
hospital-based vascular procedures.  There is evidence from the literature that smoking 
cessation rates can be increased greatly with just such a structure.  When a nurse-
managed smoking cessation intervention incorporating principles of social learning 
theory with addiction models for nicotine was implemented in the hospital with patients 
post myocardial infarction, and was followed-up with telephone calls, the smoking 
cessation rate of the intervention group was 61% versus 32% in the usual care group at 12 
months (Taylor et al., 1990).  These results were confirmed biochemically.  Even brief 
smoking cessation interventions, when combined with a teachable moment such as a 
dentist office visit, has been found to significantly increase smokeless tobacco cessation 
rates (18.4% vs. 12.5% ) (Stevens, Severson, Lischtenstein, Little, and Leben, 1995).   
In clinical settings, assessing a patients exercise self-efficacy is relatively simple, 
and should be considered as part of the initial clinical assessment of all claudicants.  For 
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claudicants with low self-efficacy, an exercise adoption intervention would be effective 
in increasing their self-efficacy, thus increasing their chance of successfully adopting a 
routine exercise regimen.  However, for claudicants with a high exercise self-efficacy 
during the baseline assessment, they may only need a one-time admonishment to begin 
walking, with reinforcement at subsequent visits.   
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Time of Dropout 
Reason Program onset During program 3-months 6-months 
General 
Medical 
 Intervention: 1 
Control: 1 
 Intervention: 2 
Cardiac  Intervention: 1  Intervention: 1 
Control: 1 
Vascular 
surgery 
   Intervention: 1  
Control: 2 
Couldnt 
contact 
Intervention: 1 Intervention:1 Intervention: 2 Intervention: 1 
Refused  Intervention: 1  Control: 1 
  
 
 
      Table 4.1.  Patient attrition during course of study and reason for loss from study 
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 Intervention group Usual Care group 
 Exercise variables Smoking 
variables 
Exercise 
variables 
Smoking 
variables 
3 months 14 (CPT,MWT,SOC) 
13 (DB) 
12 (SE) 
6 14 8 
6 months 9 (CPT,MWT) 
10 (DB,SOC,SE) 
3 12 6 
 
CPT, claudication pain time; MWT, maximal walking time; DB, decisional balance; 
SOC, stage of change; SE, self-efficacy 
 
 
 
Table 4.2:  Summary of the number of subjects available for follow-up data collection by 
group by time. 
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 Intervention group (n = 14) Usual care group (n = 
16) 
Average age 66.14 ±. 4.91 67.69 ± 2.94 
% Male 71.4 68.8 
% African American 28.6 6.3 
% Less than HS education 35.7 13.3 
% 4 year college education or 
more 
21.4 20.0 
% Current smoker 42.9 50.0 
% Never exercised before 50.0 31.3 
% With a partner who exercises 14.3 13.3 
% Hypertension 84.6 66.7 
% Previous MI 15.4 12.5 
% History CHF 7.7 6.3 
% Diabetic 57.1 31.3 
% History of Stroke 14.3 18.8 
% History of Vascular Surgery 21.4 6.3 
% Taking Pletal 35.7 50.0 
Baseline ABI .58 ±. .14 .64 ±. .11 
Baseline claudication pain time 
(minutes) 
2.65 ±. 2.04** 5.21 ±. 3.52 
Baseline maximal walking time 
(minutes) 
6.62 ±. 3.74** 10.68 ±. 5.04 
 
HS, High School; MI, Myocardial Infarction; CHF, congestive heart failure; ABI, ankle 
brachial index; ** significantly different from the usual care group. 
 
 
 
Table 4.3:  Baseline characteristics of the study sample by group. 
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Time Stage Intervention Usual 
Care 
Precontemplation/Contemplation/Preparation 100% 100% 
Action 0% 0% 
 
Baseline 
Maintenance 0% 0% 
Precontemplation/Contemplation/Preparation 14.3%** 78.6% 
Action 85.7%** 21.4% 
 
3-months 
Maintenance 0% 0% 
Precontemplation/Contemplation/Preparation 30% 41.6% 
Action 30% 41.7% 
 
6-months 
Maintenance 40% 16.7% 
 
**p < .01 significantly different from the usual care group at 3-months 
 
 
 
Table 4.4:  Percentage of subjects in each stage of exercise adoption at each time point by 
group. 
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Variable Intervention group Usual care group p value 
Claudication pain time 
 
186.5 ± 202 
(n = 14) 
70 ± 209 
(n = 14) 
.132 
Maximal walking time 
 
159 ± 170 
(n = 14) 
64 ± 191 
(n = 14) 
.176 
Smoking decisional 
balance 
4.4 ± 6.4 
(n = 5) 
8.33 ± 20.5 
(n = 9) 
.688 
Exercise decisional 
balance 
-5.5 ± 12 
(n = 12) 
-2.4 ± 12 
(n = 16) 
.502 
Exercise self-efficacy 
 
94 ± 447 
(n = 13) 
-105 ± 459 
(n = 16) 
.250 
 
Note: a negative slope indicates that the overall score decreased over time, while a 
positive slope indicates the overall score increased over time; the larger the slope, the 
greater the change over time. 
 
 
Table 4.5: Between group differences: Comparison of change over time as indicated by 
the slope value  
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 Intervention Usual Care 
Outcome 
measure 
Baseline 
 
3-months 
 
6-months 
 
Baseline 3-months 6-months 
CPT 
(minutes) 
2.7 ± 2.0  
(n = 14) 
4.5± 2.9* 
(n = 14) 
5.0 ± 3.6 * 
(n = 9) 
5.3 ± 3.7  
(n = 14) 
6.3 ± 4.5 
(n = 14) 
7.0 ± 5.1 
(n = 12) 
MWT 
(minutes) 
6.6 ±  3.7  
(n = 14) 
8.9 ± 5.2** 
(n = 14) 
8.2 ± 5.5 
(n = 9) 
10.8 ± 5.2 
(n = 14) 
11.2 ± 4.7 
(n = 14) 
12.1 ± 6.2 
(n = 12) 
Decisional 
Balance 
(mean) 
23.6 ± 9.7 
(n = 13) 
24.3 ± 11.0 
(n = 13) 
21.5 ± 10.0 
(n = 10) 
23.5 ± 13.4 
(n = 14) 
24.4 ± 10.0 
(n = 14) 
20.2 ± 9.2 
(n = 12) 
Self-efficacy 
(mean) 
831 ± 302 
(n = 12) 
923 ± 307 
(n = 12) 
782 ± 371 
(n = 10) 
819 ± 294 
(n = 14) 
762 ± 329 
(n = 14) 
684 ± 364* 
(n = 12) 
*p < .05 significantly different from baseline 
CPT, claudication pain time; MWT, maximal walking time 
 
 
 
Table 4.6.  Within group differences on the exercise measures for the intervention and 
usual care groups 
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Variable Intervention 
(n = 6) 
Usual Care 
(n = 9) 
Age years 66 60 
Carbon monoxide (ppm) 19.5 ± 11 24 ± 13 
Cotinine ng/ml 146 ± 149 
(n = 6) 
389 ± 458 
(n = 8) 
% with a partner who smoke 33% 
(n = 2) 
22% 
(n = 2) 
Mean number of years smoked regularly  48 ± 7 36 ± 15 
Mean age of smoking initiation  18 ± 6 22 ± 5 
Mean number of cigarettes/day 13 ± 6 16 ± 8 
Mean number of times tried to quit smoking 6 ± 5 7 ± 8 
Mean time to first cigarette of the day in minutes 58 ± 92 
(range 1-240) 
21 ± 19 
(range 1-60) 
% who find it difficult not to smoke in forbidden 
places 
17% 
(n = 1) 
25% 
(n = 2) 
% who smoke more frequently when they first 
get up versus the rest of the day 
67% 
(n = 4) 
63% 
(n = 5) 
% who smoke when ill enough to stay in bed 33% 
(n = 2) 
38% 
(n = 3) 
Mean Fagerstrom score (range 0-10) 6 ± 1 6 ± 1 
 
 
Table 4.7: Baseline demographics and smoking history of all self-reported smokers in the 
intervention and control groups. 
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Time Stage Intervention Usual 
Care 
Precontemplation/Contemplation/Preparation 6 11 
Action 0 0 
 
Baseline 
Maintenance 0 0 
Precontemplation/Contemplation/Preparation 5 10 
Action 1 1 
 
3-months 
Maintenance 0 0 
Precontemplation/Contemplation/Preparation 6 10 
Action 0 1 
 
6-months 
Maintenance 0 0 
Note: usual care numbers include the two subjects who said they didnt smoke but were 
smokers according to cotinine levels.  There were no significant differences between 
groups at any time point.  Those lost to follow-up was classified as a smoker 
 
 
Table 4.8: Number of all smokers in each stage of smoking cessation at each time point 
by group. 
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 Baseline 3-months 6-months 
Mean Decisional 
Balance Score 
11 ± 11 
(n = 14) 
13 ± 14 
(n = 13) 
10 ± 12 
(n = 8) 
Carbon monoxide in 
parts per million 
23 ± 12 
(n = 15) 
16 ± 11** 
(n = 13) 
16 ± 14** 
(n = 9) 
Cotinine 285 ± 371 
(n = 14) 
328 ± 298 
(n = 13) 
449 ± 445 
(n = 5) 
Note: data from the 2 subjects who stated they were non-smokers but had elevated 
cotinine levels are not on this table. 
**p < .05 significantly different from baseline 
 
 
Table 4.9:  Mean Smoking Decisional Balance Scores, Expired Carbon Monoxide and 
Cotinine values for all self-reported smokers at each time point 
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Variable Kendalls tau b correlation 
coefficient 
p value 
Baseline smoking decisional 
balance 
.523 .025 
Difficult not to smoke in 
forbidden places 
.451 .048 
 
 
Table 4.10:  Smoking variables that significantly correlated with 3-month smoking stage 
of change for all self-reported smokers. 
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Identified theme Number of smokers in this category 
Time to prepare 3 
Significant life event 5 
Effect of significant other 1 
 
 
 
Table 4.11: Themes influencing smoking cessation identified for those who quit smoking 
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note: p values indicate whether the slope is significantly different from 0 over time. 
CPT, claudication pain time in minutes 
 
 
 
Figure 4.1:  Change in CPT in minutes over time by group 
 
 
 
p = NS 
p < .01 
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note: p values indicate whether the slope is significantly different from 0 over time 
MWT, maximal walking time in minutes 
 
 
 
Figure 4.2:  Change in MWT in minutes over time by group 
 
p = NS 
p< .01 
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CHAPTER 5 
 
SUMMARY 
 Subject recruitment and data collection for the current study began in September 
1999 and was completed in February 2003.  From September 1997 until the present time, 
relevant literature related to management of PAD, the transtheoretical model, and 
principles of nicotine addition and exercise determinants were reviewed.  While there 
have been no new recommendations in the past five years regarding exercise training for 
claudicants, there was a new medication marketed by Otsuka America Pharmaceutical, 
Inc, called Cilostazol (Pletal) which began to be widely prescribed by the vascular 
surgeons in Columbus in 1999-2000.  This medication was found to significantly 
improve CPT and MWT in claudicants, and was incorporated into the current study 
(Regensteiner et al., 2002).  After talking with the collaborating vascular surgeons, it was 
decided that two months would be enough time for the medication to take effect, and 
therefore, for patients who were prescribed Pletal, and wished to be enrolled in the 
program they were required to wait two months before screening and enrollment.  This 
was done to prevent false improvements in walking time being attributed to exercise 
training.   
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A second update during the past five years came with the publication of a new 
Clinical Practice Guideline for Treating Tobacco Use and Dependence (Fiore et al., 
2000).  The guideline was reviewed for changes relevant to the current study, and of 
particular note was the lack of evidence for increased cardiovascular risk with nicotine 
replacement therapies (NRT).  One collaborating vascular surgeon specifically said he 
did not want his patients to use nicotine replacement, and as an advocate for the patient, 
this information was shared with the surgeon, and in one case, the surgeon allowed the 
patient to use NRT.   
While there have been no new recommendations in the past five years regarding 
exercise training for claudicants, it is important to note that the three critical components 
of an exercise program laid out by Gardner and Poehlman in 1995 were effective in this 
home-based exercise program.  In fact, the definition of regular exercise for this study 
was slightly less intense that that of Gardner, with a definition of three times per week for 
20 minutes per day versus 30 minutes per day.  Even so,  the concept of a walking 
intensity of near maximal claudication pain before resting, along with a frequency of 
three times/week for 20 minutes/day, and a duration of 26 weeks (6-months) was easily 
understood by this cohort of PAD patients, and was implemented to some degree by 
almost all intervention group members. 
Exercise self-efficacy has consistently been found to be a strong predictor of 
exercise behavior, the current study being no exception (McAuley and Blissmer, 2000).  
However, it was of interest that low baseline exercise self-efficacy scores could be 
overcome by an intensive nurse-managed exercise adoption intervention.  A 
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recommendation for future research includes an assessment of high intensity versus low- 
intensity nursing interventions to overcome low baseline self-efficacy in order to 
facilitate exercise adoption with PAD patients. 
While researchers have supported the value of combining smoking cessation 
interventions with hospital admissions (Taylor et al., 1990), others have suggested that 
smokers with chronic health conditions were more ready to quit smoking than the general 
population of smokers, with illness being the primary motivation for wanting to quit 
smoking (Spencer et al., 2002).  The current study revealed that at the time of the 
intervention, not all PAD patients were willing to quit smoking despite their chronic 
condition.  However, when a critical health event occurred, they were able to use the 
information obtained during the intervention to quit smoking according to self-report.  A 
recommendation for future research involves evaluating the effectiveness of a hospital-
based nurse managed intensive smoking cessation intervention with PAD patients 
admitted for a vascular procedure. 
Additional recommendations for future research include recruiting a larger sample 
size to account for variability and determine between group differences, taking baseline 
walking times into consideration when assigning patients to group, and following up with 
PAD patients for longer than six months.  This research is the first of its kind to evaluate 
the effectiveness of a nurse-managed, theory-based exercise adoption and smoking 
cessation intervention with PAD patients.  As the incidence of PAD in the elderly 
population continues to increase, there will be a greater demand for nurses to intervene to  
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help claudicants make lifestyle changes that are known to be beneficial.  Vascular nurses  
must lead the way in investigating the most effective means for counseling patients to 
begin regular exercise and quit smoking. 
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